<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub" publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">42486</article-id><article-id pub-id-type="doi">10.7554/eLife.42486</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Genetics and Genomics</subject></subj-group><subj-group subj-group-type="heading"><subject>Microbiology and Infectious Disease</subject></subj-group></article-categories><title-group><article-title>Panton–Valentine leucocidin is the key determinant of <italic>Staphylococcus aureus</italic> pyomyositis in a bacterial GWAS</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-94969"><name><surname>Young</surname><given-names>Bernadette C</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0001-6071-6770</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-123619"><name><surname>Earle</surname><given-names>Sarah G</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-0738-7557</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-132316"><name><surname>Soeng</surname><given-names>Sona</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-132526"><name><surname>Sar</surname><given-names>Poda</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-123622"><name><surname>Kumar</surname><given-names>Varun</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-123623"><name><surname>Hor</surname><given-names>Songly</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-123624"><name><surname>Sar</surname><given-names>Vuthy</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-123625"><name><surname>Bousfield</surname><given-names>Rachel</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-123626"><name><surname>Sanderson</surname><given-names>Nicholas D</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con9"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-123627"><name><surname>Barker</surname><given-names>Leanne</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con10"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-106673"><name><surname>Stoesser</surname><given-names>Nicole</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="con11"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-123628"><name><surname>Emary</surname><given-names>Katherine RW</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con12"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-123629"><name><surname>Parry</surname><given-names>Christopher M</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0001-7563-7282</contrib-id><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="aff" rid="aff8">8</xref><xref ref-type="fn" rid="con13"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-123630"><name><surname>Nickerson</surname><given-names>Emma K</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="con14"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-82706"><name><surname>Turner</surname><given-names>Paul</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-1013-7815</contrib-id><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="aff" rid="aff9">9</xref><xref ref-type="fn" rid="con15"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-124622"><name><surname>Bowden</surname><given-names>Rory</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0001-8596-0366</contrib-id><xref ref-type="aff" rid="aff10">10</xref><xref ref-type="other" rid="fund1"/><xref ref-type="fn" rid="con16"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-94982"><name><surname>Crook</surname><given-names>Derrick W</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-0590-2850</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="con17"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-94986"><name><surname>Wyllie</surname><given-names>David H</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="aff" rid="aff11">11</xref><xref ref-type="other" rid="fund2"/><xref ref-type="fn" rid="con18"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-35005"><name><surname>Day</surname><given-names>Nicholas PJ</given-names></name><xref ref-type="aff" rid="aff9">9</xref><xref ref-type="other" rid="fund3"/><xref ref-type="other" rid="fund4"/><xref ref-type="fn" rid="con19"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-4850"><name><surname>Wilson</surname><given-names>Daniel J</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-0940-3311</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff10">10</xref><xref ref-type="aff" rid="aff12">12</xref><xref ref-type="other" rid="fund5"/><xref ref-type="other" rid="fund6"/><xref ref-type="fn" rid="con20"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-122488"><name><surname>Moore</surname><given-names>Catrin E</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-8639-9846</contrib-id><email>catrin.moore@ndm.ox.ac.uk</email><xref ref-type="aff" rid="aff9">9</xref><xref ref-type="aff" rid="aff13">13</xref><xref ref-type="other" rid="fund7"/><xref ref-type="fn" rid="con21"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution content-type="dept">Nuffield Department of Medicine, Experimental Medicine Division</institution><institution>University of Oxford, John Radcliffe Hospital</institution><addr-line><named-content content-type="city">Oxford</named-content></addr-line><country>United Kingdom</country></aff><aff id="aff2"><label>2</label><institution content-type="dept">NIHR Oxford Biomedical Research Centre, Infection Theme</institution><institution>Oxford University Hospitals NHS Foundation Trust, John Radcliffe Hospital</institution><addr-line><named-content content-type="city">Oxford</named-content></addr-line><country>United Kingdom</country></aff><aff id="aff3"><label>3</label><institution content-type="dept">Cambodia Oxford Medical Research Unit</institution><institution>Angkor Hospital for Children</institution><addr-line><named-content content-type="city">Siem Reap</named-content></addr-line><country>Cambodia</country></aff><aff id="aff4"><label>4</label><institution content-type="dept">Department of Pediatrics</institution><institution>East Tennessee State University Quillen College of Medicine</institution><addr-line><named-content content-type="city">Johnson City</named-content></addr-line><country>United States</country></aff><aff id="aff5"><label>5</label><institution content-type="dept">Department of Infectious Diseases</institution><institution>Cambridge University Hospitals NHS Foundation Trust</institution><addr-line><named-content content-type="city">Cambridge</named-content></addr-line><country>United Kingdom</country></aff><aff id="aff6"><label>6</label><institution content-type="dept">Public Health England Academic Collaborating Centre</institution><institution>John Radcliffe Hospital</institution><addr-line><named-content content-type="city">Oxford</named-content></addr-line><country>United Kingdom</country></aff><aff id="aff7"><label>7</label><institution content-type="dept">Clinical Sciences</institution><institution>Liverpool School of Tropical Medicine</institution><addr-line><named-content content-type="city">Liverpool</named-content></addr-line><country>United Kingdom</country></aff><aff id="aff8"><label>8</label><institution content-type="dept">School of Tropical Medicine and Global Health</institution><institution>Nagasaki University</institution><addr-line><named-content content-type="city">Nagasaki</named-content></addr-line><country>Japan</country></aff><aff id="aff9"><label>9</label><institution content-type="dept">Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine</institution><institution>University of Oxford</institution><addr-line><named-content content-type="city">Oxford</named-content></addr-line><country>United Kingdom</country></aff><aff id="aff10"><label>10</label><institution content-type="dept">Wellcome Centre for Human Genetics</institution><institution>University of Oxford</institution><addr-line><named-content content-type="city">Oxford</named-content></addr-line><country>United Kingdom</country></aff><aff id="aff11"><label>11</label><institution content-type="dept">The Jenner Institute Laboratories</institution><institution>University of Oxford</institution><addr-line><named-content content-type="city">Oxford</named-content></addr-line><country>United Kingdom</country></aff><aff id="aff12"><label>12</label><institution content-type="dept">Institute for Emerging Infections, Oxford Martin School</institution><institution>University of Oxford</institution><addr-line><named-content content-type="city">Oxford</named-content></addr-line><country>United Kingdom</country></aff><aff id="aff13"><label>13</label><institution content-type="dept">Mahidol-Oxford Tropical Medicine Research Unit</institution><institution>Faculty of Tropical Medicine, Mahidol University</institution><addr-line><named-content content-type="city">Bangkok</named-content></addr-line><country>Thailand</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Parkhill</surname><given-names>Julian</given-names></name><role>Reviewing Editor</role><aff><institution>The Wellcome Trust Sanger Institute</institution><country>United Kingdom</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Garrett</surname><given-names>Wendy S</given-names></name><role>Senior Editor</role><aff><institution>Harvard T.H. Chan School of Public Health</institution><country>United States</country></aff></contrib></contrib-group><pub-date date-type="publication" publication-format="electronic"><day>22</day><month>02</month><year>2019</year></pub-date><pub-date pub-type="collection"><year>2019</year></pub-date><volume>8</volume><elocation-id>e42486</elocation-id><history><date date-type="received" iso-8601-date="2018-10-01"><day>01</day><month>10</month><year>2018</year></date><date date-type="accepted" iso-8601-date="2019-02-21"><day>21</day><month>02</month><year>2019</year></date></history><permissions><copyright-statement>© 2019, Young et al</copyright-statement><copyright-year>2019</copyright-year><copyright-holder>Young et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-42486-v2.pdf"/><abstract><object-id pub-id-type="doi">10.7554/eLife.42486.001</object-id><p>Pyomyositis is a severe bacterial infection of skeletal muscle, commonly affecting children in tropical regions, predominantly caused by <italic>Staphylococcus aureus</italic>. To understand the contribution of bacterial genomic factors to pyomyositis, we conducted a genome-wide association study of <italic>S. aureus</italic> cultured from 101 children with pyomyositis and 417 children with asymptomatic nasal carriage attending the Angkor Hospital for Children, Cambodia. We found a strong relationship between bacterial genetic variation and pyomyositis, with estimated heritability 63.8% (95% CI 49.2–78.4%). The presence of the Panton–Valentine leucocidin (PVL) locus increased the odds of pyomyositis 130-fold (p=10<sup>-17.9</sup>). The signal of association mapped both to the PVL-coding sequence and to the sequence immediately upstream. Together these regions explained over 99.9% of heritability (95% CI 93.5–100%). Our results establish staphylococcal pyomyositis, like tetanus and diphtheria, as critically dependent on a single toxin and demonstrate the potential for association studies to identify specific bacterial genes promoting severe human disease.</p></abstract><abstract abstract-type="executive-summary"><object-id pub-id-type="doi">10.7554/eLife.42486.002</object-id><title>eLife digest</title><p>Certain bacteria that normally live on the skin or in the nose without causing problems can sometimes lead to diseases elsewhere in the body. For example, the bacterium <italic>Staphylococcus aureus</italic> can cause blood infections or a severe and painful infection of the muscle called pyomyositis, which is very common in children who live in the tropics.</p><p>Scientists believe that pyomyositis happens when <italic>S. aureus</italic> bacteria in the blood stream infect the muscles. Some strains of this bacteria are more likely to cause such infections, but why is unclear. One potential cause is a toxin produced by some <italic>S. aureus</italic> bacteria called Panton-Valentine leucocidin (PVL). So far, studies looking at whether PVL-producing bacteria are more likely to cause pyomyositis have had conflicting results.</p><p>Now, Young et al. show that the gene for PVL is always present in <italic>S. aureus</italic> strains that cause pyomyosistis in Cambodian children, but is rarely found in <italic>S. aureus</italic> taken from the noses of their healthy counterparts. In the experiments, bacteria were collected from 101 children with pyomyositis and from the noses of 417 healthy children at the Angkor Hospital for Children in Cambodia over a 5-year period. The DNA in these bacteria were compared using very sensitive genetic techniques. The comparisons showed having the gene for PVL increased the odds of having pyomyositis 130-fold, showing that this one toxin likely accounts for much of the risk of developing this disease.</p><p>If more studies confirm the link between PVL and pyomyositis, developing vaccines that block the gene for PVL might be one way to protect children in the tropics from developing this infection. Treating children with pyomyositis with antibiotics that reduce the production of the PVL toxin may also be helpful.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd><italic>Staphylococcus aureus</italic></kwd><kwd>pyomyositis</kwd><kwd>Cambodia</kwd><kwd>genome-wide association study</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Other</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100004440</institution-id><institution>Wellcome</institution></institution-wrap></funding-source><award-id>090532/Z/09/Z</award-id><principal-award-recipient><name><surname>Bowden</surname><given-names>Rory</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100004963</institution-id><institution>Seventh Framework Programme</institution></institution-wrap></funding-source><award-id>601783</award-id><principal-award-recipient><name><surname>Wyllie</surname><given-names>David H</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100004440</institution-id><institution>Wellcome</institution></institution-wrap></funding-source><award-id>089275/H/09/Z</award-id><principal-award-recipient><name><surname>Day</surname><given-names>Nicholas PJ</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100004440</institution-id><institution>Wellcome</institution></institution-wrap></funding-source><award-id>089275/Z/09/Z</award-id><principal-award-recipient><name><surname>Day</surname><given-names>Nicholas PJ</given-names></name></principal-award-recipient></award-group><award-group id="fund5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000288</institution-id><institution>Royal Society</institution></institution-wrap></funding-source><award-id>101237/Z/13/Z</award-id><principal-award-recipient><name><surname>Wilson</surname><given-names>Daniel J</given-names></name></principal-award-recipient></award-group><award-group id="fund6"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000272</institution-id><institution>National Institute for Health Research</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Wilson</surname><given-names>Daniel J</given-names></name></principal-award-recipient></award-group><award-group id="fund7"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000769</institution-id><institution>University Of Oxford</institution></institution-wrap></funding-source><award-id>MRF/MT2015/2180</award-id><principal-award-recipient><name><surname>Moore</surname><given-names>Catrin E</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Genome-wide association studies have established staphylococcal pyomyositis as a disease whose pathogenesis depends critically on expression of a single toxin, Panton–Valentine leukocidin.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Microbial genome sequencing and bacterial genome-wide association studies (GWAS) present new opportunities to discover bacterial genes involved in the pathogenesis of serious infections (<xref ref-type="bibr" rid="bib47">Sheppard et al., 2013</xref>; <xref ref-type="bibr" rid="bib7">Chewapreecha et al., 2014</xref>; <xref ref-type="bibr" rid="bib17">Earle et al., 2016</xref>; <xref ref-type="bibr" rid="bib28">Lees et al., 2016</xref>; <xref ref-type="bibr" rid="bib18">Falush, 2016</xref>; <xref ref-type="bibr" rid="bib42">Power et al., 2017</xref>). Pyomyositis is a severe infection of skeletal muscle most commonly seen in children in the tropics (<xref ref-type="bibr" rid="bib6">Chauhan et al., 2004</xref>; <xref ref-type="bibr" rid="bib54">Verma, 2016</xref>; <xref ref-type="bibr" rid="bib2">Bickels et al., 2002</xref>). In up to 90% of cases, it is caused by a single bacterial pathogen, <italic>Staphylococcus aureus</italic> (<italic>S. aureus</italic>) (<xref ref-type="bibr" rid="bib6">Chauhan et al., 2004</xref>; <xref ref-type="bibr" rid="bib54">Verma, 2016</xref>; <xref ref-type="bibr" rid="bib2">Bickels et al., 2002</xref>; <xref ref-type="bibr" rid="bib36">Moriarty et al., 2015</xref>). Unlike infections of the skin and superficial soft tissues, the skin and subcutaneous tissues are not usually involved in pyomyositis, by contrast to intense inflammation in the infected muscles (<xref ref-type="bibr" rid="bib6">Chauhan et al., 2004</xref>; <xref ref-type="bibr" rid="bib54">Verma, 2016</xref>). Pyomyositis is thought to arise from haematogenous seeding of bacteria from blood to muscle (<xref ref-type="bibr" rid="bib54">Verma, 2016</xref>). There is evidence that some <italic>S. aureus</italic> strains have heightened propensity to cause pyomyositis – the incidence in the USA doubled during an epidemic of community-associated methicillin resistant <italic>S. aureus</italic> (CA-MRSA) (<xref ref-type="bibr" rid="bib41">Pannaraj et al., 2006</xref>) – but molecular genetic investigation of <italic>S. aureus</italic> from pyomyositis has been limited (<xref ref-type="bibr" rid="bib5">Borges et al., 2012</xref>).</p><p>Panton–Valentine leucocidin (PVL), a well-known staphylococcal toxin causing purulent skin infections and found in epidemics caused by CA-MRSA, has been implicated in pyomyositis, pneumonia and other <italic>S. aureus</italic> disease manifestations, but its role in these invasive infections is disputed (<xref ref-type="bibr" rid="bib46">Shallcross et al., 2013</xref>; <xref ref-type="bibr" rid="bib53">Vandenesch et al., 2003</xref>; <xref ref-type="bibr" rid="bib25">Labandeira-Rey et al., 2007</xref>; <xref ref-type="bibr" rid="bib55">Villaruz et al., 2009</xref>). PVL is a bipartite pore-forming toxin comprising the co-expressed LukF-PV and LukS-PV proteins (<xref ref-type="bibr" rid="bib31">Löffler et al., 2010</xref>; <xref ref-type="bibr" rid="bib3">Boakes et al., 2011</xref>). The coding sequence for PVL, <italic>lukSF-PV</italic>, is usually carried on bacteriophages, (<xref ref-type="bibr" rid="bib46">Shallcross et al., 2013</xref>; <xref ref-type="bibr" rid="bib31">Löffler et al., 2010</xref>), which facilitate <italic>lukSF-PV</italic> exchange between lineages (<xref ref-type="bibr" rid="bib33">McCarthy et al., 2012</xref>). The mechanism of PVL toxicity has been shown to involve cell lysis in human myeloid cells, particularly neutrophils, by insertion into the cellular membrane, (<xref ref-type="bibr" rid="bib38">Niemann et al., 2018</xref>) leading the tissue to release inflammatory neutrophil products (<xref ref-type="bibr" rid="bib49">Spaan et al., 2013</xref>). Neutrophil lysis is mediated by PVL binding to target complement receptors C5aR; in binding, PVL has both toxic and immunomodulatory effects, as it also inhibits C5a mediated immune activation (<xref ref-type="bibr" rid="bib48">Sina et al., 2013</xref>).</p><p>Although small case series testing for candidate genes have reported a high prevalence of PVL among pyomyositis-causing <italic>S. aureus</italic>, (<xref ref-type="bibr" rid="bib41">Pannaraj et al., 2006</xref>; <xref ref-type="bibr" rid="bib48">Sina et al., 2013</xref>; <xref ref-type="bibr" rid="bib20">García et al., 2013</xref>) a detailed meta-analysis found no evidence for an increased rate of musculoskeletal infection (or other invasive disease) in PVL-positive bacteria versus controls (<xref ref-type="bibr" rid="bib46">Shallcross et al., 2013</xref>). These conflicting results may reflect insufficiently powered studies, and some case series lack comparative control strains (<xref ref-type="bibr" rid="bib48">Sina et al., 2013</xref>). A further problem with the use of candidate gene studies in studying pathogenesis is that they may miss important variation elsewhere in the genome. One study reporting a critical role for PVL in the causation of severe pneumonia (<xref ref-type="bibr" rid="bib25">Labandeira-Rey et al., 2007</xref>) was later found to have overlooked mutations in key regulatory genes, capable of producing the virulence that had been attributed to PVL by the original study (<xref ref-type="bibr" rid="bib55">Villaruz et al., 2009</xref>). Thus, while some evidence suggests an association between pyomyositis and PVL, there remains significant uncertainty regarding the bacterial genetic predisposition of <italic>S. aureus</italic> to pyomyositis, and whether PVL is an important virulence factor, or merely an epiphenomenon, carried by bacteria alongside unidentified genetic determinants (<xref ref-type="bibr" rid="bib40">Otto, 2011</xref>; <xref ref-type="bibr" rid="bib11">Day, 2013</xref>).</p><p>GWAS offer a means to screen entire bacterial genomes to discover genes and genetic variants associated with disease risk. They are particularly appealing because they enable the investigation of traits not readily studied in the laboratory, and do not require the nomination of specific candidate genes (<xref ref-type="bibr" rid="bib18">Falush, 2016</xref>). Proof-of-principle GWAS in bacteria have demonstrated the successful rediscovery of known antimicrobial resistance (AMR) determinants (<xref ref-type="bibr" rid="bib7">Chewapreecha et al., 2014</xref>; <xref ref-type="bibr" rid="bib17">Earle et al., 2016</xref>; <xref ref-type="bibr" rid="bib28">Lees et al., 2016</xref>). However, AMR is under extraordinarily intense selection in bacteria. More subtle traits, including host specificity (<xref ref-type="bibr" rid="bib47">Sheppard et al., 2013</xref>) and the duration of pneumococcal carriage, (<xref ref-type="bibr" rid="bib29">Lees et al., 2017</xref>) have also been demonstrated using GWAS. Promising results for GWAS in human infecting bacteria include identifying possible loci for invasive infection with <italic>Streptococcus pyogenes</italic> (<xref ref-type="bibr" rid="bib28">Lees et al., 2016</xref>) and <italic>Staphylococcus epidermidis</italic> (<xref ref-type="bibr" rid="bib34">Méric et al., 2018</xref>),and the identification of virulence-associated genes corresponding with regional differences in disease manifestations of melioidosis (<xref ref-type="bibr" rid="bib8">Chewapreecha et al., 2017</xref>). Within species, lineage-specific variants have been shown to predict mortality following <italic>S. aureus</italic> bacteraemia (<xref ref-type="bibr" rid="bib43">Recker et al., 2017</xref>). These studies support the potential GWAS has to precisely pinpoint genes and genetic variants underlying the propensity to cause specific human infections, making it a promising tool to investigate the possible contribution of bacterial genomic variation to pyomyositis.</p></sec><sec id="s2" sec-type="results"><title>Results</title><p>To understand the bacterial genetic basis of pyomyositis, we sampled and whole-genome sequenced <italic>S. aureus</italic> from 101 pyomyositis infections and 417 asymptomatic nasal carriage episodes in 518 children attending Angkor Hospital for Children in Siem Reap, Cambodia between 2008 and 2012 (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>). As expected, we observed representatives of multiple globally common lineages in Cambodia, together with some globally less common lineages at high frequency, in particular clonal complex (CC) 121, identified by multi-locus sequence typing (MLST). There were no major changes in lineage frequency over time (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>).</p><p>In our study, some <italic>S. aureus</italic> lineages were strongly overrepresented among cases of pyomyositis compared with asymptomatic, nasally-carried controls over the same time period. Notably, 86/101 (85%) of pyomyositis cases were caused by CC-121 bacteria, whereas no pyomyositis cases were caused by the next two most commonly carried lineages, sequence type (ST)−834 and CC-45 (<xref ref-type="fig" rid="fig1">Figure 1</xref>). We estimated the overall heritability of case/control status to be 63.8% (95% CI 49.2–78.4%) in the sample, reflecting the strong relationship between bacterial genetic variation and case/control status. We used <italic>bugwas</italic> (<xref ref-type="bibr" rid="bib42">Power et al., 2017</xref>) to decompose this heritability into the principal components (PCs) of bacterial genetic variation. PC 1, which distinguished CC-121 (the most common pyomyositis lineage) from ST-834 (which was only found in carriage), showed the strongest association with case/control status (p=10<sup>-29.6</sup>, Wald test). The strongest association was with PC 20, which differentiated a sub-lineage of CC-121 within which no cases were seen (p=10<sup>-13.9</sup>), and PC 2, which distinguished CC-45 from the rest of the species (p=10<sup>-4.9</sup>).</p><fig-group><fig id="fig1" position="float"><object-id pub-id-type="doi">10.7554/eLife.42486.003</object-id><label>Figure 1.</label><caption><title>Phylogeny of <italic>S. aureus</italic> cultured from children in Cambodia shows strong strain-to-strain variation in pyomyositis prevalence.</title><p>The phylogeny was estimated by maximum likelihood from SNPs mapping to the USA300 FPR3757 reference genome. Multi-locus sequence type (ST) or clonal complex (CC) groups are shown (outer grey ring). Case/control status is marked in the middle ring: pyomyositis (gold, n = 101) or nasal carriage (green, n = 417). Branches of the phylogeny that correspond to the three principal components (PCs) significantly associated with case/control status (PCs 1, 2 and 20) are marked in red, blue and yellow, respectively. Branch lengths are square root transformed to aid visualization. The presence of the kmers most strongly associated with pyomyositis is indicated by red blocks in the inner ring.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-42486-fig1-v2.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.42486.004</object-id><label>Figure 1—figure supplement 1.</label><caption><title>Sampling frequencies of the major strains were stable over time.</title><p>The year of sampling (2007–2008, blue shaded lines) and MRSA status (orange lines) are illustrated around the phylogeny of the bacteria sampled from pyomyositis cases (gold lines) and asymptomatic carriage controls (green lines). The three PCs most significantly associated with case/control status are also shown (PCs 1, 2 and 20 by red, blue and yellow branches respectively). Branch lengths are square root transformed to aid visualization.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-42486-fig1-figsupp1-v2.tif"/></fig></fig-group><p>We conducted a GWAS to identify bacterial genetic variants associated with pyomyositis, controlling for differences in pyomyositis prevalence between <italic>S. aureus</italic> lineages. We used a kmer-based approach (<xref ref-type="bibr" rid="bib47">Sheppard et al., 2013</xref>) in which every variably present 31 bp DNA sequence observed among the 518 genomes was tested for association with pyomyositis <italic>versus</italic> asymptomatic nasal carriage, controlling for population structure using GEMMA (<xref ref-type="bibr" rid="bib60">Zhou and Stephens, 2012</xref>). These kmers captured bacterial genetic variation including single nucleotide polymorphisms (SNPs), insertions or deletions (indels), and presence or absence of entire accessory genes. We found 10.7 million unique kmers variably present across the bacterial genomes. In total, 9175 kmers were significantly associated with case/control status after correction for multiple testing (10<sup>-6.8</sup> ≤ <italic>p</italic> ≤ 10<sup>-21.4</sup>; <xref ref-type="fig" rid="fig2">Figure 2A</xref>). When mapped to the de novo assembly of a CC121 isolate from pyomyositis (PYO2134), the vast majority of these kmers (9,074/9,175; 98.9%) localised to a 45.7 kb region spanning an integrated prophage with 95% nucleotide identity to φSLT (<xref ref-type="fig" rid="fig2">Figure 2B</xref>). Most (9,173/9,175; 99.98%) significant kmers were found at an increased frequently in pyomyositis, with odds ratios (OR) ranging from 2.7 to 139.8, indicating that the presence of each was associated with increased risk of disease. The presence of bacteriophage φSLT was thus strongly associated with pyomyositis.</p><fig-group><fig id="fig2" position="float"><object-id pub-id-type="doi">10.7554/eLife.42486.005</object-id><label>Figure 2.</label><caption><title>Kmers associated with pyomyositis.</title><p>(<bold>A</bold>) All kmers (n = 10,744,013) were mapped to the genome assembly of one CC121 pyomyositis bacterium (PYO2134). Each point represents a kmer, plotted by the mapped location and the significance of the association with disease (-log<sub>10</sub> <italic>p</italic> value). Kmers are coloured by the odds ratio (OR) of kmer presence for disease risk. A Bonferroni-adjusted threshold for significance is plotted in grey. (<bold>B</bold>) The region between 1.57–1.62 MB in greater detail. Grey arrows depict coding sequences, determined by homology to USA300 FPR3757. (<bold>C</bold>) Associations for kmers mapping to region 1,571–1574 kB is plotted. Kmer presence determined from hybrid assembly using short and long-read data. Grey arrows depict coding sequences, determined by homology to USA300 FPR3757.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-42486-fig2-v2.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.42486.006</object-id><label>Figure 2—figure supplement 1.</label><caption><title>Alignments of reference genome PYO2134 assembly (R) with 37 de novo assemblies of Illumina short-read sequencing (C) which feature either ambiguities (Ns) or contig boundaries in the region 389 bp upstream of PVL coding sequence.</title><p>Contig boundaries, when overlapping, are marked with a red diamond. Ns in the assembly are marked in dark grey. Polymorphisms are colour-coded by base.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-42486-fig2-figsupp1-v2.tif"/></fig><fig id="fig2s2" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.42486.007</object-id><label>Figure 2—figure supplement 2.</label><caption><title>Alignments of reference genome PYO2134 assembly (R) with 37 de novo assemblies of Illumina short-read sequencing (C) which feature either ambiguities (Ns) or contig boundaries in the region 389 bp upstream of PVL coding sequence.</title><p>Contig boundaries, when overlapping, are marked with a red diamond. Ns in the assembly are marked in dark grey. Polymorphisms are colour-coded by base.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-42486-fig2-figsupp2-v2.tif"/></fig><fig id="fig2s3" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.42486.008</object-id><label>Figure 2—figure supplement 3.</label><caption><title>Presence of PVL and potential PVL carrying phages across the population.</title><p>Multi-locus sequence type (ST) or clonal complex (CC) groups are shown (outer grey ring). Case/control status is marked in the next outermost ring: pyomyositis (gold, n = 101) or nasal carriage (green, n = 417). Branch lengths are square root transformed to aid visualization. The presence of kmers mapping to the PVL coding sequence (dark red) or of &gt;98% coverage of PVL coding sequence in de novo assembly found by BLAST (red) are marked in the next rings. Phages with &gt;95% coverage on BLAST of the de novo assembly are marked by points (phiPVL in purple, φSaUSA2 in dark blue, φSLT in light blue and φCC121 in orange), and bars are used to mark the phage with the greatest sequence homology.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-42486-fig2-figsupp3-v2.tif"/></fig><fig id="fig2s4" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.42486.009</object-id><label>Figure 2—figure supplement 4.</label><caption><title>Significant association between case/control status and the presence of kmers mapping to PVL was consistent across early and late subsets.</title><p>Results from repeat kmer GWAS using early and late sub-groups of cases and controls, as well as results from original GWAS of the entire group. We report the presence of kmers mapping across the PVL locus in each subset. Forest plot showing the effect sizes (box) with 95% CI (whiskers) determined by LMM for kmers mapping to PVL kmer in each subset, and in the complete study (diamond centred on effect size extending across 95% CI). The statistical significance of association with case/control status after controlling for population structure is shown for each subset and the complete study.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-42486-fig2-figsupp4-v2.tif"/></fig></fig-group><p>We were able to localise the most statistically significant signal of association to kmers that mapped within φSLT to the <italic>lukS-PV</italic> and <italic>lukF-PV</italic> cargo genes. These genes encode the subunits of PVL, which multimerise into a pore-forming toxin capable of rapidly lysing the membranes of human neutrophils (<xref ref-type="bibr" rid="bib31">Löffler et al., 2010</xref>; <xref ref-type="bibr" rid="bib40">Otto, 2011</xref>). 1630 kmers tagging the presence of the <italic>lukSF-PV</italic> coding sequences (CDS) were highly significantly associated with disease, being present in 98/101 (97%) pyomyositis cases and 84/417 (20%) carriage controls (unadjusted OR 129.5, p=10<sup>-17.9</sup>). Kmers tagging variation in the 389 bp region immediately upstream of the CDS were also strongly associated with disease (p=10<sup>-21.4</sup>). The most significant of these kmers were co-present with the CDS in the same cases (98/101, 97.0%), but present in fewer controls (79/417, 18.9%), producing an OR of 140.</p><p>Closer examination of this ~400 bp upstream region in genomes assembled from short-read Illumina sequencing showed that assembly of the region was problematic, with breaks or gaps in the assembly (<xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2</xref>). To improve the accuracy of this region of the assembled genomes we performed long-read Oxford Nanopore sequencing on the 37 genomes with incomplete or discontinuous assembly upstream of the PVL CDS. By integrating long-read and short-read data we were able to assemble a single contig spanning this region in all isolates (<xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2</xref>). When these improved assemblies were introduced, the signal of association upstream of the PVL CDS was no more significant than within the CDS (<xref ref-type="fig" rid="fig2">Figure 2C</xref>). Therefore, the presence of genomic sequence spanning the PVL toxin-coding sequences and the upstream, presumed regulatory, region exhibited the strongest association with pyomyositis in the <italic>S. aureus</italic> genome. All isolates with kmers mapping to the PVL CDS had 98% or more coverage for the PVL CDS genes in de novo assembly (<xref ref-type="fig" rid="fig2s3">Figure 2—figure supplement 3</xref>). The signal of association in the earlier and later periods of the study were examined and found to be consistent (<xref ref-type="fig" rid="fig2s4">Figure 2—figure supplement 4</xref>).</p><p>Out of 9175 kmers significantly associated with pyomyositis, we only found 101 kmers related to regions outside the PVL-carrying prophage (<xref ref-type="fig" rid="fig2">Figure 2A</xref>, <xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref>). Two kmers mapping at a position near 0.2 Mb in the PYO2014 reference genome showed homology to platelet adhesin <italic>sraP</italic> by BLAST. Thirty-five kmers mapping to a 50 bp non-coding fragment at 0.6 Mb and two kmers mapping to 2.8 Mb showed homology to an MSSA476 intergenic sequence between adhesin-encoding <italic>sdrC</italic> and <italic>sdrD</italic> by BLAST. One kmer mapping to position 2.0 Mb showed no sequence homology by BLAST. Sixty-one kmers mapping to a 61 bp non-coding region at 2.7 Mb showed homology to an MSSA476 intergenic sequence between acetyltransferase-encoding genes SAS2453 and SAS2454 by BLAST. In conclusion, these other signals were short, fragmentary and mostly non-coding so we did not investigate them further.</p><p>The presence of high-risk kmers mapping to the PVL region explained the vast majority of observed heritability. When the presence or absence of the most significant kmer pattern, a set of kmers with an identical pattern of presence in the population, all of which mapped to the PVL region, was included as a covariate in GEMMA, the remaining heritability not explained by other factors was estimated and found to be 0.0% (95% CI 0–2.5%). Thus, the point estimate for heritability (not explained by the inclusion of PVL-tagging kmers) is reduced by 100% (95% CI 93.5–100%), meaning we have little evidence for any remaining heritability in case/control status.</p><p>Presence or absence of the PVL region accounted for the differences in pyomyositis rates between lineages. It was common in pyomyositis-associated lineages including CC-121 and absent from carriage/non-pyomyositis-associated lineages including ST-834 and CC-45 (<xref ref-type="fig" rid="fig1">Figure 1</xref>), explaining over 99.9% of observed heritability in case-control status. It was infrequent in the non-pyomyositis-associated sub-lineage of CC-121 (2/36, 5.6%), and sporadically present in pyomyositis cases in otherwise non-pyomyositis-associated, PVL-negative strains CC-1 and CC-88. Its absence from only three cases (in lineages CC-88, CC-1 and CC-121) suggested that the PVL region approached necessity for development of pyomyositis in the current setting in Cambodian children, while its presence in 20% of controls indicated that PVL-associated pyomyositis is incompletely penetrant, that is presence of the PVL region does not always lead to disease.</p><p>PVL genes were carried on multiple genetic backgrounds in this population, and the phage backgrounds vary by clonal complex. We examined all assemblies for sequence similarity to six known bacteriophages that carry the PVL genes, (<xref ref-type="bibr" rid="bib3">Boakes et al., 2011</xref>) as well as the 45.7 kb region in PYO2134, a hypothesised integrated prophage identified in the reference genome prepared for this study, which we have called φCC121 (<xref ref-type="fig" rid="fig2s3">Figure 2—figure supplement 3</xref>). The finding of PVL genes on BLAST corresponded completely with the presence of kmers mapping across the PVL locus. We find sequences with &gt;95% homology to four of these seven phages in the population. Regions in some assemblies showed homology for multiple phages, reflecting the similarity between jSLT, jSa2USA and jCC121 rather than the presence of multiple phages, and resolution of phages was limited by fragmented assemblies from short reads (Supplementary File 2B). Phage types were restricted within most lineages, with jSLT found in ST-3206, jSa2USA in ST-1232 and jPVL in CC-1. jCC121 was the phage most often identified in the dominant pyomyositis strain CC-121, but it was absent in all but one isolate from the low risk subclade within CC-121. Strikingly, PVL-negative isolates in CC-121 and ST-834 strains frequently retained sequence homologous to &gt;95% of jSLT, suggesting that some PVL-negative CC-121 isolates lost PVL secondarily by gene deletion rather than prophage excision.</p></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>In this study, we found a strong association between pyomyositis, a highly distinctive tropical infection of skeletal muscle in children, and Panton-Valentine leukocidin, a bacterial toxin commonly carried by bacteriophages. We found that a single coding region together with the upstream sequence are all but necessary for the development of pyomyositis: its sporadic presence is associated with pyomyositis in otherwise low-frequency strains, and its absence is associated with asymptomatic carriage in a high-propensity strain. PVL appears to be carried on multiple phage backgrounds in this population, but PVL-positive lineages generally carry a single phage type, as expected given the observed strain restriction of phages in <italic>S. aureus</italic> (<xref ref-type="bibr" rid="bib57">Xia and Wolz, 2014</xref>; <xref ref-type="bibr" rid="bib51">Stegger et al., 2014</xref>). The locally common PVL-positive CC-121 lineage contributes most strongly to the prevalence of pyomyositis in Cambodian children.</p><p>While PVL has long been thought an important <italic>S. aureus</italic> virulence factor, (<xref ref-type="bibr" rid="bib15">Diep et al., 2008</xref>; <xref ref-type="bibr" rid="bib4">Bocchini et al., 2006</xref>; <xref ref-type="bibr" rid="bib24">Kurt et al., 2013</xref>) its role in invasive disease has been controversial, (<xref ref-type="bibr" rid="bib40">Otto, 2011</xref>; <xref ref-type="bibr" rid="bib11">Day, 2013</xref>) with conflicting results in case-control studies and an absence of supporting evidence on meta-analysis (<xref ref-type="bibr" rid="bib46">Shallcross et al., 2013</xref>). In previous studies, the PVL-positive USA300 lineage was associated with musculoskeletal infection (both pyomyositis and osteomyelitis), however in these studies almost all such infections were caused by the USA300 strain, so the role of PVL was almost completely confounded by both methicillin resistance and strain background (<xref ref-type="bibr" rid="bib41">Pannaraj et al., 2006</xref>; <xref ref-type="bibr" rid="bib4">Bocchini et al., 2006</xref>). In our study, this confounding influence is broken down by the movement of PVL on mobile genetic elements (MGEs). Despite the emergence of CA-MRSA in carriage in Cambodia (<xref ref-type="bibr" rid="bib37">Nickerson et al., 2011</xref>), all the pyomyositis cases were MSSA (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>). By applying a GWAS method to a well-powered cohort, our study resolves the controversy around pyomyositis and PVL, demonstrating strong heritability which localises to a single region, even when the full bacterial genome is considered. Bacterial GWAS can pinpoint virulence variants when MGEs act to unravel linkage disequilibrium, if effect sizes are sufficiently strong.</p><p>There is strong biological plausibility for the association demonstrated in this study. PVL is a well characterised <italic>S. aureus</italic> toxin, toxic to the myeloid cells that form a first line of defence against bacterial infection, (<xref ref-type="bibr" rid="bib39">Oliveira et al., 2018</xref>) and, in binding to myeloid cells by a complement receptor (C5aR), exerts immunomodulatory effects (<xref ref-type="bibr" rid="bib49">Spaan et al., 2013</xref>). The establishment of muscle abscesses is a critical step in the pathogenesis of pyomyositis, but unlike renal, hepatic and splenic abscesses, skeletal muscle abscesses are rarely observed in experimental models of bacteraemia, unless there is preceding muscle trauma (<xref ref-type="bibr" rid="bib35">Miyake, 1904</xref>). <italic>S. aureus</italic> strains containing PVL show increased duration of bacteraemia in a rabbit model of sepsis, (<xref ref-type="bibr" rid="bib57">Xia and Wolz, 2014</xref>) and result in larger muscle abscesses (<xref ref-type="bibr" rid="bib52">Tseng et al., 2009</xref>). PVL has been found strongly bound to necrotic muscle in an individual with myositis associated with necrotizing fasciitis (<xref ref-type="bibr" rid="bib30">Lehman et al., 2010</xref>). These observations support the hypothesis that PVL may facilitate bacterial seeding to muscles via the bloodstream and tropism for muscular infection.</p><p>These results establish that, for children in Cambodia, staphylococcal pyomyositis is a disease whose pathogenesis depends crucially on a single toxin. This property is shared by toxin-driven, vaccine-preventable diseases such as tetanus and diphtheria. Therefore, vaccines that generate neutralising anti-toxin antibodies against PVL (<xref ref-type="bibr" rid="bib26">Landrum et al., 2017</xref>) might protect human populations specifically against this common tropical disease. These results also raise the hypothesis that antibiotics which decrease toxin expression, and have been recommended in some PVL-associated infections, (<xref ref-type="bibr" rid="bib45">Saeed et al., 2018</xref>) may offer specific clinical benefit in treating pyomyositis. More generally, our study provides an example of how microbial GWAS can be used to elucidate the pathogenesis of bacterial infections and identify specific virulence genes associated with human disease.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><sec id="s4-1"><title>Patient sample collection</title><p>We retrospectively identified pyomyositis cases from the Angkor Hospital for Children in Siem Reap, Cambodia, between January 2007 and November 2011. We screened all attendances in children (≤16 years) using clinical coding (ICD-10 code M60 (myositis)) and isolation of <italic>S. aureus</italic> from skeletal muscle abscess pus. We reviewed clinical notes to confirm a clinical diagnosis of pyomyositis was made by the medical staff, and bacterial strains cultured by routine clinical microbiology laboratory were retrieved from the local microbiology biobank. 106 clinical episodes of pyomyositis were identified, in 101 individuals, and we included the earliest episode from each individual.</p><p>We identified <italic>S. aureus</italic> nasal colonisation from two cohort studies undertaken at Angkor Hospital for Children. The first were selected from a collection characterising nasal colonization in the region between September and October, 2008, which has previously been described using multi-locus sequence typing (<xref ref-type="bibr" rid="bib37">Nickerson et al., 2011</xref>). The swabs had been saved at −80°C since the study, these samples were re-examined for the presence of <italic>S. aureus</italic> using selective agar, confirmed using Staphaurex (Remel, Lenexa, USA) and the DNAse agar test (Oxoid, Hampshire, UK). Antimicrobial susceptibility testing was performed according to the 2014 Clinical and Laboratory Standards Institute guidelines (M100-24) (<xref ref-type="bibr" rid="bib9">CLSI, 2014</xref>).</p><p>We undertook a second cohort study in 2012. Inclusion criteria were children (≤16 years) attending as an outpatient at Angkor Hospital for Children with informed consent. There were no exclusion criteria. Children were swabbed between the 2-7th July 2012, using sterile cotton tipped swabs pre-moistened (with phosphate buffered saline, PBS) using three full rotations of the swab within the anterior portion of each nostril with one swab being used for both nostrils, the ends were broken into bottles containing sterile PBS and kept cool until plated in the laboratory (within the hour). The swabs were plated onto Mannitol Salt agar to select for <italic>S. aureus</italic>. The M100-24 CLSI (<xref ref-type="bibr" rid="bib9">CLSI, 2014</xref>) standards were followed for susceptibility testing and bacteria stored in tryptone soya broth and glycerol at −80°C.</p><p>We selected controls from carriers in these two cohorts using the excel randomization function: 222 of 519 from the 2008 cohort and 195 of 261 from the 2012 cohort.</p></sec><sec id="s4-2"><title>Ethical framework</title><p>Approval for this study was provided by the AHC institutional review board and the Oxford Tropical Ethics Committee (507-12).</p></sec><sec id="s4-3"><title>Whole genome sequencing</title><p>For each bacterial culture, a single colony was sub-cultured and DNA was extracted from the sub-cultured plate using a mechanical lysis step (FastPrep; MPBiomedicals, Santa Ana, CA) followed by a commercial kit (QuickGene; Autogen Inc, Holliston, MA), and sequenced at the Wellcome Centre for Human Genetics, Oxford on the Illumina (San Diego, California, USA) HiSeq 2500 platform, with paired-end reads 150 base pairs long.</p><p>A subset of samples were sequenced using long-read sequencing technology. We selected 37 isolates with incomplete assembly upstream of the PVL locus, 22 with ambiguous base calls in the assembly, and 15 where the region was assembled over two contigs. DNA was extracted using Genomic Tip 100/G (Qiagen, Manchester, UK) and DNA libraries prepared using Oxford Nanopore Technologies (ONT) SQK-LSK108 library kit (ONT, Oxford, UK) according to manufacturer instructions. These were then sequenced on ONT GridION device integrated with a FLO-MIN106 flow cell (ONT, Oxford, UK). ONT base calling was performed using Guppy v.1.6.</p></sec><sec id="s4-4"><title>Variant calling</title><p>For short-read sequencing, we used Velvet (<xref ref-type="bibr" rid="bib59">Zerbino and Birney, 2008</xref>) v1.0.18 to assemble reads into contigs de novo. Velvet Optimiser v2.1.7 was used to choose the kmer lengths on a per sequence basis. The median kmer length was 123 bp (IQR 119–123). To obtain multilocus sequence types we used BLAST (<xref ref-type="bibr" rid="bib1">Altschul et al., 1990</xref>) to find the relevant loci, and looked up the nucleotide sequences in the online database at <ext-link ext-link-type="uri" xlink:href="http://saureus.mlst.net/.">http://saureus.mlst.net/.</ext-link> Strains that shared 6 of 7 MLST loci were considered to be in the same Clonal Complex (<xref ref-type="bibr" rid="bib19">Feil et al., 2003</xref>). Antibiotic sensitivity was predicted by interrogating the assemblies for a panel of resistance determinants as previously described (<xref ref-type="bibr" rid="bib22">Gordon et al., 2014</xref>).</p><p>We used Stampy (<xref ref-type="bibr" rid="bib32">Lunter and Goodson, 2011</xref>) v1.0.22 to map reads against reference genomes (USA300_FPR3757, Genbank accession number CP000255.1) (<xref ref-type="bibr" rid="bib14">Diep et al., 2006</xref>). Repetitive regions, defined by BLAST (<xref ref-type="bibr" rid="bib1">Altschul et al., 1990</xref>) comparison of the reference genome against itself, were masked prior to variant calling. Bases were called at each position using previously described quality filters (<xref ref-type="bibr" rid="bib12">Didelot et al., 2012</xref>; <xref ref-type="bibr" rid="bib58">Young et al., 2012</xref>; <xref ref-type="bibr" rid="bib21">Golubchik et al., 2013</xref>).</p><p>After filtering ONT reads with filtlong v.0.2.0 (with settings filtlong -- min_length 1000 --keep_percent 90 --target_bases 500000000 --trim --split 500), hybrid assembly of short (Illumina) and long (ONT) reads were made, using Unicycler v0.4.5 (<xref ref-type="bibr" rid="bib56">Wick et al., 2017</xref>) (default settings). The workflow for these assemblies is available at <ext-link ext-link-type="uri" xlink:href="https://gitlab.com/ModernisingMedicalMicrobiology/MOHAWK">https://gitlab.com/ModernisingMedicalMicrobiology/MOHAWK</ext-link>)</p></sec><sec id="s4-5"><title>Reconstructing the phylogenetic tree</title><p>We constructed a maximum likelihood phylogeny of mapped genomes for visualization using RAxML (<xref ref-type="bibr" rid="bib50">Stamatakis, 2014</xref>) assuming a general time reversible (GTR) model. To overcome a limitation in the presence of divergent sequences whereby RAxML fixes a minimum branch length that may be longer than a single substitution event, we fine-tuned the estimates of branch lengths using ClonalFrameML (<xref ref-type="bibr" rid="bib13">Didelot and Wilson, 2015</xref>).</p></sec><sec id="s4-6"><title>Kmer counting</title><p>We used a kmer-based approach to capture non-SNP variation (<xref ref-type="bibr" rid="bib47">Sheppard et al., 2013</xref>). Using the de novo assembled genome, all unique 31 base haplotypes were counted using dsk (<xref ref-type="bibr" rid="bib44">Rizk et al., 2013</xref>). If a kmer was found in the assembly, it was counted present for that genome, otherwise it was treated as absent. This produced a set of 10,744,013 variably present kmers, with the presence or absence of each determined per isolate. We identified a median of 2,801,000 kmers per isolate, including variably present kmers and kmers common to all genomes (IQR 2,778,000–2,837,000).</p></sec><sec id="s4-7"><title>Calculating heritability</title><p>We used the Genome-wide Efficient Mixed Model Association tool (GEMMA (<xref ref-type="bibr" rid="bib60">Zhou and Stephens, 2012</xref>)) to fit a univariate linear mixed model for association between a single phenotype (pyomyositis vs asymptomatic nasal carriage). We calculated the relatedness matrix from kmers, and used GEMMA to estimate the proportion of variance in phenotypes explained by genotypic diversity in the sample set (i.e. estimated heritability). Heritability estimates with and without a covariate (e.g. the presence of high risk kmers) are compared by testing for difference in proportions. We use the point estimate for heritability as the denominator to calculate the relative decrease proportion.</p></sec><sec id="s4-8"><title>Genome wide association testing of kmers</title><p>We performed association testing using an R package bacterialGWAS (<ext-link ext-link-type="uri" xlink:href="https://github.com/jessiewu/bacterialGWAS">https://github.com/jessiewu/bacterialGWAS</ext-link>), which implements a published method for locus testing in bacterial GWAS (<xref ref-type="bibr" rid="bib17">Earle et al., 2016</xref>). The association of each kmer on the phenotype was tested, controlling for the population structure and genetic background using a linear mixed model (LMM) implemented in GEMMA (<xref ref-type="bibr" rid="bib20">García et al., 2013</xref>). The parameters of the linear mixed model were estimated by maximum likelihood and likelihood ratio test was performed against the null hypothesis (that each locus has no effect) using the software GEMMA (<xref ref-type="bibr" rid="bib20">García et al., 2013</xref>). GEMMA was run using a minor allele frequency of 0 to include all SNPs. GEMMA was modified to output the ML log-likelihood under the null, and alternative and –log<sub>10</sub> <italic>p</italic> values were calculated using R scripts in the bacterialGWAS package. Unadjusted odds ratios were reported because there was no residual heritability unexplained by the most significant kmers.</p><p>To address the possibility of differing effect sizes between the two control cohorts, we have repeated the analysis after splitting the study into two groups – early (2008 and earlier, n = 276, cases n = 54, controls n = 222) and late (2009 and later, n = 242, cases n = 47, controls n = 195). We then examined the maximum likelihood estimates produced by the LMM for kmers mapping to the PVL coding sequence in each region. The 95% CI of the estimate from each sub study were overlapping (See <xref ref-type="fig" rid="fig2s4">Figure 2—figure supplement 4</xref>).</p></sec><sec id="s4-9"><title>Testing for lineage effects</title><p>We tested for associations between lineage and phenotype using an R package <italic>bugwas</italic> (available at <ext-link ext-link-type="uri" xlink:href="https://github.com/sgearle/bugwas">https://github.com/sgearle/bugwas</ext-link>), which implements a published method for lineage testing in bacterial GWAS (<xref ref-type="bibr" rid="bib17">Earle et al., 2016</xref>). We tested lineages using principal components. These were computed based on biallelic SNPs using the R function prcomp. To test the null hypothesis of no background effect of each principal component, we used a Wald test, which we compared against a <italic>χ</italic> (<xref ref-type="bibr" rid="bib7">Chewapreecha et al., 2014</xref>) distribution with one degree of freedom to obtain a <italic>p</italic> value.</p></sec><sec id="s4-10"><title>Kmer mapping</title><p>We used Bowtie (<xref ref-type="bibr" rid="bib27">Langmead and Salzberg, 2012</xref>) to align all 31 bp kmers from short-read sequencing to a draft reference (the de novo assembly of a CC-121 pyomyosits strain PYO2134). Areas of homology between the draft reference and well-annotated reference strains were identified by aligning sequences with Mauve (<xref ref-type="bibr" rid="bib10">Darling et al., 2004</xref>). For all 31 bp kmers with significant association with case-controls status, the likely origin of the kmer was determined by nucleotide sequence BLAST (<xref ref-type="bibr" rid="bib1">Altschul et al., 1990</xref>) of the kmers against a database of all <italic>S. aureus</italic> sequences in Genbank.</p></sec><sec id="s4-11"><title>Joint short-read and long-read analysis</title><p>31 bp kmers were counted for the 37 hybrid short-read and long-read assemblies using dsk (<xref ref-type="bibr" rid="bib44">Rizk et al., 2013</xref>). The presence or absence of all Illumina (short-read) kmers that mapped to the two PVL toxin-coding sequences and the upstream intergenic region plus the surrounding 1 kb were reassessed. For the 37 samples with hybrid assemblies, the presence/absence of these kmers was determined from the kmers counted from the hybrid assemblies. For all other samples, presence/absence was determined from the kmers counted from the short-read only assemblies. The new presence/absence patterns were tested for association with the phenotype controlling for population structure and genetic background using GEMMA (<xref ref-type="bibr" rid="bib60">Zhou and Stephens, 2012</xref>), using the same relatedness matrix as the original short-read analysis.</p></sec><sec id="s4-12"><title>Predicting presence of PVL genes and bacteriophages</title><p>We used BLAST to check for the relative coverage of the PVL CDS (From reference genome USA300_FPR3757 (CP000255.1) positions 1546170–1548350), as well as the entire sequence of 6 known PVL positive phages (φ2958(NC_011344.1), φPVL (NC_002321.1), φPVL108 (NC_008689.1), φSLT (NC_002661.2), φSa2MW (NC_003923.1), φSa2USA (CP000255.1)) (<xref ref-type="bibr" rid="bib3">Boakes et al., 2011</xref>), as well as the hypothesised prophage region from PYO2134 (1571177–1616957), which we have calledφCC121. For PVL genes, we determined relative coverage of the query sequence; over 98% coverage was used as threshold for gene presence.</p></sec><sec id="s4-13"><title>Multiple testing correction</title><p>Multiple testing was accounted for by applying a Bonferroni correction (<xref ref-type="bibr" rid="bib16">Dunn, 1959</xref>); the individual locus effect of a variant (kmer or PC) was considered significant if its <italic>P</italic> value was smaller than <italic>α</italic>/<italic>n</italic><sub>p</sub>, where we took <italic>α</italic> = 0.05 to be the genome-wide false-positive rate and <italic>n</italic><sub>p</sub> to be the number of kmers or PCs with unique phylogenetic patterns, that is, unique partitions of individuals according to allele membership. We identified 236627 unique kmer patterns and 518 PCs, giving thresholds of 2.1 × 10<sup>−7</sup> and 9.7 × 10<sup>−5</sup> respectively.</p></sec><sec id="s4-14"><title>Data availability</title><p>Sequence data have been submitted to Short Read Archive (Bioproject ID PRJNA418899). Clinical origins of sequenced strains are listed in supplementary information (<xref ref-type="supplementary-material" rid="supp4">Supplementary File 4</xref>).</p></sec></sec></body><back><ack id="ack"><title>Acknowledgments</title><p>The authors would like to thank study participants. This study was funded by the Wellcome Trust (MORU Grants 089275/H/09/Z and 089275/Z/09/Z), and a University of Oxford Medical Research Fund awarded to CEM (MRF/MT2015/2180). DJW is a Sir Henry Dale Fellow, jointly funded by the Wellcome Trust and the Royal Society (Grant 101237/Z/13/Z). BCY is a Research Training Fellow funded by the Wellcome Trust (Grant 101611/Z/13/Z). DHW was funded by the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC) and the European Union’s Seventh Framework Programme under the grant agreement number 601783 (BELLEROPHON project). NS is funded by a Public Health England (PHE)/University of Oxford Clinical Lectureship. KE was funded by an academic clinical fellowship which was provided by the UK NIHR through the University of Oxford. This research was supported by Core funding to the Wellcome Centre for Human Genetics provided by the Wellcome (090532/Z/09/Z). The views expressed are those of the author(s) and not necessarily those of the NHS, PHE, the NIHR or the Department of Health.</p></ack><sec id="s5" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Investigation, Visualization, Methodology, Writing—original draft, Writing—review and editing</p></fn><fn fn-type="con" id="con2"><p>Data curation, Formal analysis, Methodology, Writing—review and editing</p></fn><fn fn-type="con" id="con3"><p>Investigation, Methodology</p></fn><fn fn-type="con" id="con4"><p>Investigation, Methodology</p></fn><fn fn-type="con" id="con5"><p>Conceptualization, Writing—review and editing</p></fn><fn fn-type="con" id="con6"><p>Investigation, Writing—review and editing</p></fn><fn fn-type="con" id="con7"><p>Investigation, Writing—review and editing</p></fn><fn fn-type="con" id="con8"><p>Data curation, Investigation, Writing—review and editing</p></fn><fn fn-type="con" id="con9"><p>Investigation, Methodology, Writing—review and editing</p></fn><fn fn-type="con" id="con10"><p>Investigation, Methodology, Writing—review and editing</p></fn><fn fn-type="con" id="con11"><p>Investigation, Writing—review and editing</p></fn><fn fn-type="con" id="con12"><p>Conceptualization, Investigation, Writing—review and editing</p></fn><fn fn-type="con" id="con13"><p>Conceptualization, Investigation, Methodology, Writing—review and editing</p></fn><fn fn-type="con" id="con14"><p>Investigation, Methodology, Writing—review and editing</p></fn><fn fn-type="con" id="con15"><p>Investigation, Writing—review and editing</p></fn><fn fn-type="con" id="con16"><p>Investigation, Writing—review and editing</p></fn><fn fn-type="con" id="con17"><p>Investigation, Writing—review and editing</p></fn><fn fn-type="con" id="con18"><p>Investigation, Writing—review and editing</p></fn><fn fn-type="con" id="con19"><p>Conceptualization, Supervision, Writing—review and editing</p></fn><fn fn-type="con" id="con20"><p>Resources, Supervision, Writing—original draft, Writing—review and editing</p></fn><fn fn-type="con" id="con21"><p>Conceptualization, Resources, Data curation, Formal analysis, Supervision, Funding acquisition, Investigation, Methodology, Writing—original draft, Project administration, Writing—review and editing</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Human subjects: Approval for this study was provided by the AHC institutional review board and the Oxford Tropical Ethics Committee (507-12).</p></fn></fn-group></sec><sec id="s6" sec-type="supplementary-material"><title>Additional files</title><supplementary-material id="supp1"><object-id pub-id-type="doi">10.7554/eLife.42486.010</object-id><label>Supplementary file 1.</label><caption><title>Isolates included in this study.</title></caption><media mime-subtype="docx" mimetype="application" xlink:href="elife-42486-supp1-v2.docx"/></supplementary-material><supplementary-material id="supp2"><object-id pub-id-type="doi">10.7554/eLife.42486.011</object-id><label>Supplementary file 2.</label><caption><title>All significant kmers from short-read sequencing assembly, evidence of association, frequency, location on mapping to the study reference PYO2134, best match on BLAST (blastn) to all <italic>S. aureus</italic> coding sequences in Genbank, and best match on BLAST (blastn) to the NCBI database.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-42486-supp2-v2.xlsx"/></supplementary-material><supplementary-material id="supp3"><object-id pub-id-type="doi">10.7554/eLife.42486.012</object-id><label>Supplementary file 3.</label><caption><title>Presence of high risk kmers and relative coverage of PVL coding sequence and common PVL positive phages found by BLAST (blastn) of short read assemblies.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-42486-supp3-v2.xlsx"/></supplementary-material><supplementary-material id="supp4"><object-id pub-id-type="doi">10.7554/eLife.42486.013</object-id><label>Supplementary file 4.</label><caption><title>List of all isolates, and site of isolation (carriage or invasive disease) and year of isolation.</title><p>These isolate names match those used in sequence data deposition on SRA.</p></caption><media mime-subtype="octet-stream" mimetype="application" xlink:href="elife-42486-supp4-v2.csv"/></supplementary-material><supplementary-material id="transrepform"><object-id pub-id-type="doi">10.7554/eLife.42486.014</object-id><label>Transparent reporting form</label><media mime-subtype="pdf" mimetype="application" xlink:href="elife-42486-transrepform-v2.pdf"/></supplementary-material></sec><sec id="s7" sec-type="data-availability"><title>Data availability</title><p>Sequence data has been submitted to Short Read Archive (Bioproject ID PRJNA418899).</p><p>The following dataset was generated:</p><p><element-citation id="dataset1" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><name><surname>Young</surname><given-names>BC</given-names></name><name><surname>Earle</surname><given-names>SG</given-names></name><name><surname>Soeng</surname><given-names>S</given-names></name><name><surname>Sar</surname><given-names>P</given-names></name><name><surname>Kumar</surname><given-names>V</given-names></name><name><surname>Hor</surname><given-names>S</given-names></name><name><surname>Sar</surname><given-names>V</given-names></name><name><surname>Bousfield</surname><given-names>R</given-names></name><name><surname>Sanderson</surname><given-names>ND</given-names></name><name><surname>Barker</surname><given-names>L</given-names></name><name><surname>Stoesser</surname><given-names>N</given-names></name><name><surname>Emary</surname><given-names>KRW</given-names></name><name><surname>Parry</surname><given-names>CM</given-names></name><name><surname>Nickerson</surname><given-names>EK</given-names></name><name><surname>Turner</surname><given-names>P</given-names></name><name><surname>Bowden</surname><given-names>R</given-names></name><name><surname>Crook</surname><given-names>D</given-names></name><name><surname>Wyllie</surname><given-names>D</given-names></name><name><surname>Day</surname><given-names>NPJ</given-names></name></person-group><year iso-8601-date="2018">2018</year><data-title>A genome-wide association study of S. aureus cultured from 101 children with pyomyositis and 417 children with asymptomatic nasal carriage attending the Angkor Hospital for Children in Cambodia</data-title><source>NCBI Bioproject</source><pub-id assigning-authority="NCBI" pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/bioproject/?term=PRJNA418899">PRJNA418899</pub-id></element-citation></p></sec><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Altschul</surname> <given-names>SF</given-names></name><name><surname>Gish</surname> <given-names>W</given-names></name><name><surname>Miller</surname> <given-names>W</given-names></name><name><surname>Myers</surname> <given-names>EW</given-names></name><name><surname>Lipman</surname> <given-names>DJ</given-names></name></person-group><year iso-8601-date="1990">1990</year><article-title>Basic local alignment search tool</article-title><source>Journal of Molecular Biology</source><volume>215</volume><fpage>403</fpage><lpage>410</lpage><pub-id pub-id-type="doi">10.1016/S0022-2836(05)80360-2</pub-id><pub-id pub-id-type="pmid">2231712</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bickels</surname> <given-names>J</given-names></name><name><surname>Ben-Sira</surname> <given-names>L</given-names></name><name><surname>Kessler</surname> <given-names>A</given-names></name><name><surname>Wientroub</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Primary pyomyositis</article-title><source>The Journal of Bone and Joint Surgery-American Volume</source><volume>84</volume><fpage>2277</fpage><lpage>2286</lpage><pub-id pub-id-type="doi">10.2106/00004623-200212000-00024</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boakes</surname> <given-names>E</given-names></name><name><surname>Kearns</surname> <given-names>AM</given-names></name><name><surname>Ganner</surname> <given-names>M</given-names></name><name><surname>Perry</surname> <given-names>C</given-names></name><name><surname>Hill</surname> <given-names>RL</given-names></name><name><surname>Ellington</surname> <given-names>MJ</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Distinct bacteriophages encoding Panton-Valentine leukocidin (PVL) among international methicillin-resistant staphylococcus aureus clones harboring PVL</article-title><source>Journal of Clinical Microbiology</source><volume>49</volume><fpage>684</fpage><lpage>692</lpage><pub-id pub-id-type="doi">10.1128/JCM.01917-10</pub-id><pub-id pub-id-type="pmid">21106787</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bocchini</surname> <given-names>CE</given-names></name><name><surname>Hulten</surname> <given-names>KG</given-names></name><name><surname>Mason</surname> <given-names>EO</given-names></name><name><surname>Gonzalez</surname> <given-names>BE</given-names></name><name><surname>Hammerman</surname> <given-names>WA</given-names></name><name><surname>Kaplan</surname> <given-names>SL</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Panton-Valentine leukocidin genes are associated with enhanced inflammatory response and local disease in acute hematogenous <italic>staphylococcus aureus</italic> osteomyelitis in children</article-title><source>Pediatrics</source><volume>117</volume><fpage>433</fpage><lpage>440</lpage><pub-id pub-id-type="doi">10.1542/peds.2005-0566</pub-id><pub-id pub-id-type="pmid">16452363</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Borges</surname> <given-names>AH</given-names></name><name><surname>Faragher</surname> <given-names>B</given-names></name><name><surname>Lalloo</surname> <given-names>DG</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Pyomyositis in the upper negro river basin, brazilian Amazonia</article-title><source>Transactions of the Royal Society of Tropical Medicine and Hygiene</source><volume>106</volume><fpage>532</fpage><lpage>537</lpage><pub-id pub-id-type="doi">10.1016/j.trstmh.2012.06.008</pub-id><pub-id pub-id-type="pmid">22819770</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chauhan</surname> <given-names>S</given-names></name><name><surname>Jain</surname> <given-names>S</given-names></name><name><surname>Varma</surname> <given-names>S</given-names></name><name><surname>Chauhan</surname> <given-names>SS</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Tropical pyomyositis (myositis tropicans): current perspective</article-title><source>Postgraduate Medical Journal</source><volume>80</volume><fpage>267</fpage><lpage>270</lpage><pub-id pub-id-type="doi">10.1136/pgmj.2003.009274</pub-id><pub-id pub-id-type="pmid">15138315</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chewapreecha</surname> <given-names>C</given-names></name><name><surname>Marttinen</surname> <given-names>P</given-names></name><name><surname>Croucher</surname> <given-names>NJ</given-names></name><name><surname>Salter</surname> <given-names>SJ</given-names></name><name><surname>Harris</surname> <given-names>SR</given-names></name><name><surname>Mather</surname> <given-names>AE</given-names></name><name><surname>Hanage</surname> <given-names>WP</given-names></name><name><surname>Goldblatt</surname> <given-names>D</given-names></name><name><surname>Nosten</surname> <given-names>FH</given-names></name><name><surname>Turner</surname> <given-names>C</given-names></name><name><surname>Turner</surname> <given-names>P</given-names></name><name><surname>Bentley</surname> <given-names>SD</given-names></name><name><surname>Parkhill</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Comprehensive identification of single nucleotide polymorphisms associated with beta-lactam resistance within pneumococcal mosaic genes</article-title><source>PLoS Genetics</source><volume>10</volume><elocation-id>e1004547</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1004547</pub-id><pub-id pub-id-type="pmid">25101644</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chewapreecha</surname> <given-names>C</given-names></name><name><surname>Holden</surname> <given-names>MT</given-names></name><name><surname>Vehkala</surname> <given-names>M</given-names></name><name><surname>Välimäki</surname> <given-names>N</given-names></name><name><surname>Yang</surname> <given-names>Z</given-names></name><name><surname>Harris</surname> <given-names>SR</given-names></name><name><surname>Mather</surname> <given-names>AE</given-names></name><name><surname>Tuanyok</surname> <given-names>A</given-names></name><name><surname>De Smet</surname> <given-names>B</given-names></name><name><surname>Le Hello</surname> <given-names>S</given-names></name><name><surname>Bizet</surname> <given-names>C</given-names></name><name><surname>Mayo</surname> <given-names>M</given-names></name><name><surname>Wuthiekanun</surname> <given-names>V</given-names></name><name><surname>Limmathurotsakul</surname> <given-names>D</given-names></name><name><surname>Phetsouvanh</surname> <given-names>R</given-names></name><name><surname>Spratt</surname> <given-names>BG</given-names></name><name><surname>Corander</surname> <given-names>J</given-names></name><name><surname>Keim</surname> <given-names>P</given-names></name><name><surname>Dougan</surname> <given-names>G</given-names></name><name><surname>Dance</surname> <given-names>DA</given-names></name><name><surname>Currie</surname> <given-names>BJ</given-names></name><name><surname>Parkhill</surname> <given-names>J</given-names></name><name><surname>Peacock</surname> <given-names>SJ</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Global and regional dissemination and evolution of <italic>burkholderia pseudomallei</italic></article-title><source>Nature Microbiology</source><volume>2</volume><elocation-id>16263</elocation-id><pub-id pub-id-type="doi">10.1038/nmicrobiol.2016.263</pub-id><pub-id pub-id-type="pmid">28112723</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="book"><person-group person-group-type="author"><collab>CLSI</collab></person-group><year iso-8601-date="2014">2014</year><source>Performance Standards for Antimicrobial Susceptibility Testing</source><edition>24th ed</edition><publisher-loc>Wayne</publisher-loc><publisher-name>Clinical and Laboratory Standards Institute</publisher-name></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Darling</surname> <given-names>AC</given-names></name><name><surname>Mau</surname> <given-names>B</given-names></name><name><surname>Blattner</surname> <given-names>FR</given-names></name><name><surname>Perna</surname> <given-names>NT</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Mauve: multiple alignment of conserved genomic sequence with rearrangements</article-title><source>Genome Research</source><volume>14</volume><fpage>1394</fpage><lpage>1403</lpage><pub-id pub-id-type="doi">10.1101/gr.2289704</pub-id><pub-id pub-id-type="pmid">15231754</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Day</surname> <given-names>NP</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Panton-Valentine leucocidin and staphylococcal disease</article-title><source>The Lancet Infectious Diseases</source><volume>13</volume><fpage>5</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1016/S1473-3099(12)70265-7</pub-id><pub-id pub-id-type="pmid">23103174</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Didelot</surname> <given-names>X</given-names></name><name><surname>Eyre</surname> <given-names>DW</given-names></name><name><surname>Cule</surname> <given-names>M</given-names></name><name><surname>Ip</surname> <given-names>CL</given-names></name><name><surname>Ansari</surname> <given-names>MA</given-names></name><name><surname>Griffiths</surname> <given-names>D</given-names></name><name><surname>Vaughan</surname> <given-names>A</given-names></name><name><surname>O'Connor</surname> <given-names>L</given-names></name><name><surname>Golubchik</surname> <given-names>T</given-names></name><name><surname>Batty</surname> <given-names>EM</given-names></name><name><surname>Piazza</surname> <given-names>P</given-names></name><name><surname>Wilson</surname> <given-names>DJ</given-names></name><name><surname>Bowden</surname> <given-names>R</given-names></name><name><surname>Donnelly</surname> <given-names>PJ</given-names></name><name><surname>Dingle</surname> <given-names>KE</given-names></name><name><surname>Wilcox</surname> <given-names>M</given-names></name><name><surname>Walker</surname> <given-names>AS</given-names></name><name><surname>Crook</surname> <given-names>DW</given-names></name><name><surname>Peto</surname> <given-names>TE</given-names></name><name><surname>Harding</surname> <given-names>RM</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Microevolutionary analysis of <italic>clostridium difficile</italic> genomes to investigate transmission</article-title><source>Genome Biology</source><volume>13</volume><elocation-id>R118</elocation-id><pub-id pub-id-type="doi">10.1186/gb-2012-13-12-r118</pub-id><pub-id pub-id-type="pmid">23259504</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Didelot</surname> <given-names>X</given-names></name><name><surname>Wilson</surname> <given-names>DJ</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>ClonalFrameML: efficient inference of recombination in whole bacterial genomes</article-title><source>PLOS Computational Biology</source><volume>11</volume><elocation-id>e1004041</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pcbi.1004041</pub-id><pub-id pub-id-type="pmid">25675341</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Diep</surname> <given-names>BA</given-names></name><name><surname>Gill</surname> <given-names>SR</given-names></name><name><surname>Chang</surname> <given-names>RF</given-names></name><name><surname>Phan</surname> <given-names>TH</given-names></name><name><surname>Chen</surname> <given-names>JH</given-names></name><name><surname>Davidson</surname> <given-names>MG</given-names></name><name><surname>Lin</surname> <given-names>F</given-names></name><name><surname>Lin</surname> <given-names>J</given-names></name><name><surname>Carleton</surname> <given-names>HA</given-names></name><name><surname>Mongodin</surname> <given-names>EF</given-names></name><name><surname>Sensabaugh</surname> <given-names>GF</given-names></name><name><surname>Perdreau-Remington</surname> <given-names>F</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Complete genome sequence of USA300, an epidemic clone of community-acquired meticillin-resistant <italic>staphylococcus aureus</italic></article-title><source>The Lancet</source><volume>367</volume><fpage>731</fpage><lpage>739</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(06)68231-7</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Diep</surname> <given-names>BA</given-names></name><name><surname>Palazzolo-Ballance</surname> <given-names>AM</given-names></name><name><surname>Tattevin</surname> <given-names>P</given-names></name><name><surname>Basuino</surname> <given-names>L</given-names></name><name><surname>Braughton</surname> <given-names>KR</given-names></name><name><surname>Whitney</surname> <given-names>AR</given-names></name><name><surname>Chen</surname> <given-names>L</given-names></name><name><surname>Kreiswirth</surname> <given-names>BN</given-names></name><name><surname>Otto</surname> <given-names>M</given-names></name><name><surname>DeLeo</surname> <given-names>FR</given-names></name><name><surname>Chambers</surname> <given-names>HF</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Contribution of Panton-Valentine leukocidin in community-associated methicillin-resistant <italic>staphylococcus aureus</italic> pathogenesis</article-title><source>PLoS ONE</source><volume>3</volume><elocation-id>e3198</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0003198</pub-id><pub-id pub-id-type="pmid">18787708</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dunn</surname> <given-names>OJ</given-names></name></person-group><year iso-8601-date="1959">1959</year><article-title>Estimation of the medians for dependent variables</article-title><source>The Annals of Mathematical Statistics</source><volume>30</volume><fpage>192</fpage><lpage>197</lpage><pub-id pub-id-type="doi">10.1214/aoms/1177706374</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Earle</surname> <given-names>SG</given-names></name><name><surname>Wu</surname> <given-names>CH</given-names></name><name><surname>Charlesworth</surname> <given-names>J</given-names></name><name><surname>Stoesser</surname> <given-names>N</given-names></name><name><surname>Gordon</surname> <given-names>NC</given-names></name><name><surname>Walker</surname> <given-names>TM</given-names></name><name><surname>Spencer</surname> <given-names>CCA</given-names></name><name><surname>Iqbal</surname> <given-names>Z</given-names></name><name><surname>Clifton</surname> <given-names>DA</given-names></name><name><surname>Hopkins</surname> <given-names>KL</given-names></name><name><surname>Woodford</surname> <given-names>N</given-names></name><name><surname>Smith</surname> <given-names>EG</given-names></name><name><surname>Ismail</surname> <given-names>N</given-names></name><name><surname>Llewelyn</surname> <given-names>MJ</given-names></name><name><surname>Peto</surname> <given-names>TE</given-names></name><name><surname>Crook</surname> <given-names>DW</given-names></name><name><surname>McVean</surname> <given-names>G</given-names></name><name><surname>Walker</surname> <given-names>AS</given-names></name><name><surname>Wilson</surname> <given-names>DJ</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Identifying lineage effects when controlling for population structure improves power in bacterial association studies</article-title><source>Nature Microbiology</source><volume>1</volume><elocation-id>16041</elocation-id><pub-id pub-id-type="doi">10.1038/nmicrobiol.2016.41</pub-id><pub-id pub-id-type="pmid">27572646</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Falush</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Bacterial genomics: microbial GWAS coming of age</article-title><source>Nature Microbiology</source><volume>1</volume><elocation-id>16059</elocation-id><pub-id pub-id-type="doi">10.1038/nmicrobiol.2016.59</pub-id><pub-id pub-id-type="pmid">27572652</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feil</surname> <given-names>EJ</given-names></name><name><surname>Cooper</surname> <given-names>JE</given-names></name><name><surname>Grundmann</surname> <given-names>H</given-names></name><name><surname>Robinson</surname> <given-names>DA</given-names></name><name><surname>Enright</surname> <given-names>MC</given-names></name><name><surname>Berendt</surname> <given-names>T</given-names></name><name><surname>Peacock</surname> <given-names>SJ</given-names></name><name><surname>Smith</surname> <given-names>JM</given-names></name><name><surname>Murphy</surname> <given-names>M</given-names></name><name><surname>Spratt</surname> <given-names>BG</given-names></name><name><surname>Moore</surname> <given-names>CE</given-names></name><name><surname>Day</surname> <given-names>NP</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>How clonal is <italic>staphylococcus aureus</italic>?</article-title><source>Journal of Bacteriology</source><volume>185</volume><fpage>3307</fpage><lpage>3316</lpage><pub-id pub-id-type="doi">10.1128/JB.185.11.3307-3316.2003</pub-id><pub-id pub-id-type="pmid">12754228</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>García</surname> <given-names>C</given-names></name><name><surname>Hallin</surname> <given-names>M</given-names></name><name><surname>Deplano</surname> <given-names>A</given-names></name><name><surname>Denis</surname> <given-names>O</given-names></name><name><surname>Sihuincha</surname> <given-names>M</given-names></name><name><surname>de Groot</surname> <given-names>R</given-names></name><name><surname>Gotuzzo</surname> <given-names>E</given-names></name><name><surname>Jacobs</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title><italic>Staphylococcus aureus</italic> causing tropical pyomyositis, Amazon Basin, Peru</article-title><source>Emerging Infectious Diseases</source><volume>19</volume><fpage>123</fpage><lpage>125</lpage><pub-id pub-id-type="doi">10.3201/eid1901.120819</pub-id><pub-id pub-id-type="pmid">23260279</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Golubchik</surname> <given-names>T</given-names></name><name><surname>Batty</surname> <given-names>EM</given-names></name><name><surname>Miller</surname> <given-names>RR</given-names></name><name><surname>Farr</surname> <given-names>H</given-names></name><name><surname>Young</surname> <given-names>BC</given-names></name><name><surname>Larner-Svensson</surname> <given-names>H</given-names></name><name><surname>Fung</surname> <given-names>R</given-names></name><name><surname>Godwin</surname> <given-names>H</given-names></name><name><surname>Knox</surname> <given-names>K</given-names></name><name><surname>Votintseva</surname> <given-names>A</given-names></name><name><surname>Everitt</surname> <given-names>RG</given-names></name><name><surname>Street</surname> <given-names>T</given-names></name><name><surname>Cule</surname> <given-names>M</given-names></name><name><surname>Ip</surname> <given-names>CL</given-names></name><name><surname>Didelot</surname> <given-names>X</given-names></name><name><surname>Peto</surname> <given-names>TE</given-names></name><name><surname>Harding</surname> <given-names>RM</given-names></name><name><surname>Wilson</surname> <given-names>DJ</given-names></name><name><surname>Crook</surname> <given-names>DW</given-names></name><name><surname>Bowden</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Within-host evolution of <italic>staphylococcus aureus</italic> during asymptomatic carriage</article-title><source>PLoS ONE</source><volume>8</volume><elocation-id>e61319</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0061319</pub-id><pub-id pub-id-type="pmid">23658690</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gordon</surname> <given-names>NC</given-names></name><name><surname>Price</surname> <given-names>JR</given-names></name><name><surname>Cole</surname> <given-names>K</given-names></name><name><surname>Everitt</surname> <given-names>R</given-names></name><name><surname>Morgan</surname> <given-names>M</given-names></name><name><surname>Finney</surname> <given-names>J</given-names></name><name><surname>Kearns</surname> <given-names>AM</given-names></name><name><surname>Pichon</surname> <given-names>B</given-names></name><name><surname>Young</surname> <given-names>B</given-names></name><name><surname>Wilson</surname> <given-names>DJ</given-names></name><name><surname>Llewelyn</surname> <given-names>MJ</given-names></name><name><surname>Paul</surname> <given-names>J</given-names></name><name><surname>Peto</surname> <given-names>TE</given-names></name><name><surname>Crook</surname> <given-names>DW</given-names></name><name><surname>Walker</surname> <given-names>AS</given-names></name><name><surname>Golubchik</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Prediction of staphylococcus aureus antimicrobial resistance by whole-genome sequencing</article-title><source>Journal of Clinical Microbiology</source><volume>52</volume><fpage>1182</fpage><lpage>1191</lpage><pub-id pub-id-type="doi">10.1128/JCM.03117-13</pub-id><pub-id pub-id-type="pmid">24501024</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Holden</surname> <given-names>MT</given-names></name><name><surname>Feil</surname> <given-names>EJ</given-names></name><name><surname>Lindsay</surname> <given-names>JA</given-names></name><name><surname>Peacock</surname> <given-names>SJ</given-names></name><name><surname>Day</surname> <given-names>NP</given-names></name><name><surname>Enright</surname> <given-names>MC</given-names></name><name><surname>Foster</surname> <given-names>TJ</given-names></name><name><surname>Moore</surname> <given-names>CE</given-names></name><name><surname>Hurst</surname> <given-names>L</given-names></name><name><surname>Atkin</surname> <given-names>R</given-names></name><name><surname>Barron</surname> <given-names>A</given-names></name><name><surname>Bason</surname> <given-names>N</given-names></name><name><surname>Bentley</surname> <given-names>SD</given-names></name><name><surname>Chillingworth</surname> <given-names>C</given-names></name><name><surname>Chillingworth</surname> <given-names>T</given-names></name><name><surname>Churcher</surname> <given-names>C</given-names></name><name><surname>Clark</surname> <given-names>L</given-names></name><name><surname>Corton</surname> <given-names>C</given-names></name><name><surname>Cronin</surname> <given-names>A</given-names></name><name><surname>Doggett</surname> <given-names>J</given-names></name><name><surname>Dowd</surname> <given-names>L</given-names></name><name><surname>Feltwell</surname> <given-names>T</given-names></name><name><surname>Hance</surname> <given-names>Z</given-names></name><name><surname>Harris</surname> <given-names>B</given-names></name><name><surname>Hauser</surname> <given-names>H</given-names></name><name><surname>Holroyd</surname> <given-names>S</given-names></name><name><surname>Jagels</surname> <given-names>K</given-names></name><name><surname>James</surname> <given-names>KD</given-names></name><name><surname>Lennard</surname> <given-names>N</given-names></name><name><surname>Line</surname> <given-names>A</given-names></name><name><surname>Mayes</surname> <given-names>R</given-names></name><name><surname>Moule</surname> <given-names>S</given-names></name><name><surname>Mungall</surname> <given-names>K</given-names></name><name><surname>Ormond</surname> <given-names>D</given-names></name><name><surname>Quail</surname> <given-names>MA</given-names></name><name><surname>Rabbinowitsch</surname> <given-names>E</given-names></name><name><surname>Rutherford</surname> <given-names>K</given-names></name><name><surname>Sanders</surname> <given-names>M</given-names></name><name><surname>Sharp</surname> <given-names>S</given-names></name><name><surname>Simmonds</surname> <given-names>M</given-names></name><name><surname>Stevens</surname> <given-names>K</given-names></name><name><surname>Whitehead</surname> <given-names>S</given-names></name><name><surname>Barrell</surname> <given-names>BG</given-names></name><name><surname>Spratt</surname> <given-names>BG</given-names></name><name><surname>Parkhill</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Complete genomes of two clinical <italic>staphylococcus aureus</italic> strains: evidence for the rapid evolution of virulence and drug resistance</article-title><source>PNAS</source><volume>101</volume><fpage>9786</fpage><lpage>9791</lpage><pub-id pub-id-type="doi">10.1073/pnas.0402521101</pub-id><pub-id pub-id-type="pmid">15213324</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kurt</surname> <given-names>K</given-names></name><name><surname>Rasigade</surname> <given-names>JP</given-names></name><name><surname>Laurent</surname> <given-names>F</given-names></name><name><surname>Goering</surname> <given-names>RV</given-names></name><name><surname>Žemličková</surname> <given-names>H</given-names></name><name><surname>Machova</surname> <given-names>I</given-names></name><name><surname>Struelens</surname> <given-names>MJ</given-names></name><name><surname>Zautner</surname> <given-names>AE</given-names></name><name><surname>Holtfreter</surname> <given-names>S</given-names></name><name><surname>Bröker</surname> <given-names>B</given-names></name><name><surname>Ritchie</surname> <given-names>S</given-names></name><name><surname>Reaksmey</surname> <given-names>S</given-names></name><name><surname>Limmathurotsakul</surname> <given-names>D</given-names></name><name><surname>Peacock</surname> <given-names>SJ</given-names></name><name><surname>Cuny</surname> <given-names>C</given-names></name><name><surname>Layer</surname> <given-names>F</given-names></name><name><surname>Witte</surname> <given-names>W</given-names></name><name><surname>Nübel</surname> <given-names>U</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Subpopulations of <italic>staphylococcus aureus</italic> clonal complex 121 are associated with distinct clinical entities</article-title><source>PLoS ONE</source><volume>8</volume><elocation-id>e58155</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0058155</pub-id><pub-id pub-id-type="pmid">23505464</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Labandeira-Rey</surname> <given-names>M</given-names></name><name><surname>Couzon</surname> <given-names>F</given-names></name><name><surname>Boisset</surname> <given-names>S</given-names></name><name><surname>Brown</surname> <given-names>EL</given-names></name><name><surname>Bes</surname> <given-names>M</given-names></name><name><surname>Benito</surname> <given-names>Y</given-names></name><name><surname>Barbu</surname> <given-names>EM</given-names></name><name><surname>Vazquez</surname> <given-names>V</given-names></name><name><surname>Höök</surname> <given-names>M</given-names></name><name><surname>Etienne</surname> <given-names>J</given-names></name><name><surname>Vandenesch</surname> <given-names>F</given-names></name><name><surname>Bowden</surname> <given-names>MG</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title><italic>Staphylococcus aureus</italic> Panton-Valentine leukocidin causes necrotizing pneumonia</article-title><source>Science</source><volume>315</volume><fpage>1130</fpage><lpage>1133</lpage><pub-id pub-id-type="doi">10.1126/science.1137165</pub-id><pub-id pub-id-type="pmid">17234914</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Landrum</surname> <given-names>ML</given-names></name><name><surname>Lalani</surname> <given-names>T</given-names></name><name><surname>Niknian</surname> <given-names>M</given-names></name><name><surname>Maguire</surname> <given-names>JD</given-names></name><name><surname>Hospenthal</surname> <given-names>DR</given-names></name><name><surname>Fattom</surname> <given-names>A</given-names></name><name><surname>Taylor</surname> <given-names>K</given-names></name><name><surname>Fraser</surname> <given-names>J</given-names></name><name><surname>Wilkins</surname> <given-names>K</given-names></name><name><surname>Ellis</surname> <given-names>MW</given-names></name><name><surname>Kessler</surname> <given-names>PD</given-names></name><name><surname>Fahim</surname> <given-names>RE</given-names></name><name><surname>Tribble</surname> <given-names>DR</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Safety and immunogenicity of a recombinant <italic>staphylococcus aureus</italic> α-toxoid and a recombinant Panton-Valentine leukocidin subunit, in healthy adults</article-title><source>Human Vaccines &amp; Immunotherapeutics</source><volume>13</volume><fpage>791</fpage><lpage>801</lpage><pub-id pub-id-type="doi">10.1080/21645515.2016.1248326</pub-id><pub-id pub-id-type="pmid">28010246</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Langmead</surname> <given-names>B</given-names></name><name><surname>Salzberg</surname> <given-names>SL</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Fast gapped-read alignment with Bowtie 2</article-title><source>Nature Methods</source><volume>9</volume><fpage>357</fpage><lpage>359</lpage><pub-id pub-id-type="doi">10.1038/nmeth.1923</pub-id><pub-id pub-id-type="pmid">22388286</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lees</surname> <given-names>JA</given-names></name><name><surname>Vehkala</surname> <given-names>M</given-names></name><name><surname>Välimäki</surname> <given-names>N</given-names></name><name><surname>Harris</surname> <given-names>SR</given-names></name><name><surname>Chewapreecha</surname> <given-names>C</given-names></name><name><surname>Croucher</surname> <given-names>NJ</given-names></name><name><surname>Marttinen</surname> <given-names>P</given-names></name><name><surname>Davies</surname> <given-names>MR</given-names></name><name><surname>Steer</surname> <given-names>AC</given-names></name><name><surname>Tong</surname> <given-names>SY</given-names></name><name><surname>Honkela</surname> <given-names>A</given-names></name><name><surname>Parkhill</surname> <given-names>J</given-names></name><name><surname>Bentley</surname> <given-names>SD</given-names></name><name><surname>Corander</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Sequence element enrichment analysis to determine the genetic basis of bacterial phenotypes</article-title><source>Nature Communications</source><volume>7</volume><elocation-id>12797</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms12797</pub-id><pub-id pub-id-type="pmid">27633831</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lees</surname> <given-names>JA</given-names></name><name><surname>Croucher</surname> <given-names>NJ</given-names></name><name><surname>Goldblatt</surname> <given-names>D</given-names></name><name><surname>Nosten</surname> <given-names>F</given-names></name><name><surname>Parkhill</surname> <given-names>J</given-names></name><name><surname>Turner</surname> <given-names>C</given-names></name><name><surname>Turner</surname> <given-names>P</given-names></name><name><surname>Bentley</surname> <given-names>SD</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Genome-wide identification of lineage and locus specific variation associated with pneumococcal carriage duration</article-title><source>eLife</source><volume>6</volume><elocation-id>e26255</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.26255</pub-id><pub-id pub-id-type="pmid">28742023</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lehman</surname> <given-names>D</given-names></name><name><surname>Tseng</surname> <given-names>CW</given-names></name><name><surname>Eells</surname> <given-names>S</given-names></name><name><surname>Miller</surname> <given-names>LG</given-names></name><name><surname>Fan</surname> <given-names>X</given-names></name><name><surname>Beenhouwer</surname> <given-names>DO</given-names></name><name><surname>Liu</surname> <given-names>GY</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title><italic>Staphylococcus aureus</italic> Panton-Valentine leukocidin targets muscle tissues in a child with myositis and necrotizing fasciitis</article-title><source>Clinical Infectious Diseases</source><volume>50</volume><fpage>69</fpage><lpage>72</lpage><pub-id pub-id-type="doi">10.1086/649217</pub-id><pub-id pub-id-type="pmid">19995216</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Löffler</surname> <given-names>B</given-names></name><name><surname>Hussain</surname> <given-names>M</given-names></name><name><surname>Grundmeier</surname> <given-names>M</given-names></name><name><surname>Brück</surname> <given-names>M</given-names></name><name><surname>Holzinger</surname> <given-names>D</given-names></name><name><surname>Varga</surname> <given-names>G</given-names></name><name><surname>Roth</surname> <given-names>J</given-names></name><name><surname>Kahl</surname> <given-names>BC</given-names></name><name><surname>Proctor</surname> <given-names>RA</given-names></name><name><surname>Peters</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title><italic>Staphylococcus aureus</italic> panton-valentine leukocidin is a very potent cytotoxic factor for human neutrophils</article-title><source>PLoS Pathogens</source><volume>6</volume><elocation-id>e1000715</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1000715</pub-id><pub-id pub-id-type="pmid">20072612</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lunter</surname> <given-names>G</given-names></name><name><surname>Goodson</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Stampy: a statistical algorithm for sensitive and fast mapping of illumina sequence reads</article-title><source>Genome Research</source><volume>21</volume><fpage>936</fpage><lpage>939</lpage><pub-id pub-id-type="doi">10.1101/gr.111120.110</pub-id><pub-id pub-id-type="pmid">20980556</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McCarthy</surname> <given-names>AJ</given-names></name><name><surname>Witney</surname> <given-names>AA</given-names></name><name><surname>Lindsay</surname> <given-names>JA</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title><italic>Staphylococcus aureus</italic> temperate bacteriophage: carriage and horizontal gene transfer is lineage associated</article-title><source>Frontiers in Cellular and Infection Microbiology</source><volume>2</volume><elocation-id>6</elocation-id><pub-id pub-id-type="doi">10.3389/fcimb.2012.00006</pub-id><pub-id pub-id-type="pmid">22919598</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Méric</surname> <given-names>G</given-names></name><name><surname>Mageiros</surname> <given-names>L</given-names></name><name><surname>Pensar</surname> <given-names>J</given-names></name><name><surname>Laabei</surname> <given-names>M</given-names></name><name><surname>Yahara</surname> <given-names>K</given-names></name><name><surname>Pascoe</surname> <given-names>B</given-names></name><name><surname>Kittiwan</surname> <given-names>N</given-names></name><name><surname>Tadee</surname> <given-names>P</given-names></name><name><surname>Post</surname> <given-names>V</given-names></name><name><surname>Lamble</surname> <given-names>S</given-names></name><name><surname>Bowden</surname> <given-names>R</given-names></name><name><surname>Bray</surname> <given-names>JE</given-names></name><name><surname>Morgenstern</surname> <given-names>M</given-names></name><name><surname>Jolley</surname> <given-names>KA</given-names></name><name><surname>Maiden</surname> <given-names>MCJ</given-names></name><name><surname>Feil</surname> <given-names>EJ</given-names></name><name><surname>Didelot</surname> <given-names>X</given-names></name><name><surname>Miragaia</surname> <given-names>M</given-names></name><name><surname>de Lencastre</surname> <given-names>H</given-names></name><name><surname>Moriarty</surname> <given-names>TF</given-names></name><name><surname>Rohde</surname> <given-names>H</given-names></name><name><surname>Massey</surname> <given-names>R</given-names></name><name><surname>Mack</surname> <given-names>D</given-names></name><name><surname>Corander</surname> <given-names>J</given-names></name><name><surname>Sheppard</surname> <given-names>SK</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Disease-associated genotypes of the commensal skin bacterium <italic>staphylococcus epidermidis</italic></article-title><source>Nature Communications</source><volume>9</volume><elocation-id>5034</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-018-07368-7</pub-id><pub-id pub-id-type="pmid">30487573</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miyake</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="1904">1904</year><article-title>Beitragezurkenntnis der sogenannten myositis infectiosa</article-title><source>Mitt Grenageb Med Chir</source><volume>13</volume><fpage>155</fpage><lpage>198</lpage></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moriarty</surname> <given-names>P</given-names></name><name><surname>Leung</surname> <given-names>C</given-names></name><name><surname>Walsh</surname> <given-names>M</given-names></name><name><surname>Nourse</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Increasing pyomyositis presentations among children in Queensland, Australia</article-title><source>The Pediatric Infectious Disease Journal</source><volume>34</volume><fpage>1</fpage><lpage>4</lpage><pub-id pub-id-type="doi">10.1097/INF.0000000000000470</pub-id><pub-id pub-id-type="pmid">24983716</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nickerson</surname> <given-names>EK</given-names></name><name><surname>Wuthiekanun</surname> <given-names>V</given-names></name><name><surname>Kumar</surname> <given-names>V</given-names></name><name><surname>Amornchai</surname> <given-names>P</given-names></name><name><surname>Wongdeethai</surname> <given-names>N</given-names></name><name><surname>Chheng</surname> <given-names>K</given-names></name><name><surname>Chantratita</surname> <given-names>N</given-names></name><name><surname>Putchhat</surname> <given-names>H</given-names></name><name><surname>Thaipadungpanit</surname> <given-names>J</given-names></name><name><surname>Day</surname> <given-names>NP</given-names></name><name><surname>Peacock</surname> <given-names>SJ</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Emergence of community-associated methicillin-resistant <italic>staphylococcus aureus</italic> carriage in children in Cambodia</article-title><source>The American Journal of Tropical Medicine and Hygiene</source><volume>84</volume><fpage>313</fpage><lpage>317</lpage><pub-id pub-id-type="doi">10.4269/ajtmh.2011.10-0300</pub-id><pub-id pub-id-type="pmid">21292906</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Niemann</surname> <given-names>S</given-names></name><name><surname>Bertling</surname> <given-names>A</given-names></name><name><surname>Brodde</surname> <given-names>MF</given-names></name><name><surname>Fender</surname> <given-names>AC</given-names></name><name><surname>Van de Vyver</surname> <given-names>H</given-names></name><name><surname>Hussain</surname> <given-names>M</given-names></name><name><surname>Holzinger</surname> <given-names>D</given-names></name><name><surname>Reinhardt</surname> <given-names>D</given-names></name><name><surname>Peters</surname> <given-names>G</given-names></name><name><surname>Heilmann</surname> <given-names>C</given-names></name><name><surname>Löffler</surname> <given-names>B</given-names></name><name><surname>Kehrel</surname> <given-names>BE</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Panton-Valentine leukocidin associated with <italic>S. aureus</italic> osteomyelitis activates platelets via neutrophil secretion products</article-title><source>Scientific Reports</source><volume>8</volume><elocation-id>2185</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-018-20582-z</pub-id><pub-id pub-id-type="pmid">29391581</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oliveira</surname> <given-names>D</given-names></name><name><surname>Borges</surname> <given-names>A</given-names></name><name><surname>Simões</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title><italic>Staphylococcus aureus</italic> toxins and their molecular activity in infectious diseases</article-title><source>Toxins</source><volume>10</volume><elocation-id>252</elocation-id><pub-id pub-id-type="doi">10.3390/toxins10060252</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Otto</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>A MRSA-terious enemy among Us: end of the PVL controversy?</article-title><source>Nature Medicine</source><volume>17</volume><fpage>169</fpage><lpage>170</lpage><pub-id pub-id-type="doi">10.1038/nm0211-169</pub-id><pub-id pub-id-type="pmid">21297612</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pannaraj</surname> <given-names>PS</given-names></name><name><surname>Hulten</surname> <given-names>KG</given-names></name><name><surname>Gonzalez</surname> <given-names>BE</given-names></name><name><surname>Mason</surname> <given-names>EO</given-names></name><name><surname>Kaplan</surname> <given-names>SL</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Infective pyomyositis and myositis in children in the era of community-acquired, methicillin-resistant <italic>staphylococcus aureus</italic> infection</article-title><source>Clinical Infectious Diseases</source><volume>43</volume><fpage>953</fpage><lpage>960</lpage><pub-id pub-id-type="doi">10.1086/507637</pub-id><pub-id pub-id-type="pmid">16983604</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Power</surname> <given-names>RA</given-names></name><name><surname>Parkhill</surname> <given-names>J</given-names></name><name><surname>de Oliveira</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Microbial genome-wide association studies: lessons from human GWAS</article-title><source>Nature Reviews Genetics</source><volume>18</volume><fpage>41</fpage><lpage>50</lpage><pub-id pub-id-type="doi">10.1038/nrg.2016.132</pub-id><pub-id pub-id-type="pmid">27840430</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Recker</surname> <given-names>M</given-names></name><name><surname>Laabei</surname> <given-names>M</given-names></name><name><surname>Toleman</surname> <given-names>MS</given-names></name><name><surname>Reuter</surname> <given-names>S</given-names></name><name><surname>Saunderson</surname> <given-names>RB</given-names></name><name><surname>Blane</surname> <given-names>B</given-names></name><name><surname>Török</surname> <given-names>ME</given-names></name><name><surname>Ouadi</surname> <given-names>K</given-names></name><name><surname>Stevens</surname> <given-names>E</given-names></name><name><surname>Yokoyama</surname> <given-names>M</given-names></name><name><surname>Steventon</surname> <given-names>J</given-names></name><name><surname>Thompson</surname> <given-names>L</given-names></name><name><surname>Milne</surname> <given-names>G</given-names></name><name><surname>Bayliss</surname> <given-names>S</given-names></name><name><surname>Bacon</surname> <given-names>L</given-names></name><name><surname>Peacock</surname> <given-names>SJ</given-names></name><name><surname>Massey</surname> <given-names>RC</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Clonal differences in <italic>staphylococcus aureus</italic> bacteraemia-associated mortality</article-title><source>Nature Microbiology</source><volume>2</volume><fpage>1381</fpage><lpage>1388</lpage><pub-id pub-id-type="doi">10.1038/s41564-017-0001-x</pub-id><pub-id pub-id-type="pmid">28785103</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rizk</surname> <given-names>G</given-names></name><name><surname>Lavenier</surname> <given-names>D</given-names></name><name><surname>Chikhi</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>DSK: k-mer counting with very low memory usage</article-title><source>Bioinformatics</source><volume>29</volume><fpage>652</fpage><lpage>653</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btt020</pub-id><pub-id pub-id-type="pmid">23325618</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saeed</surname> <given-names>K</given-names></name><name><surname>Gould</surname> <given-names>I</given-names></name><name><surname>Esposito</surname> <given-names>S</given-names></name><name><surname>Ahmad-Saeed</surname> <given-names>N</given-names></name><name><surname>Ahmed</surname> <given-names>SS</given-names></name><name><surname>Alp</surname> <given-names>E</given-names></name><name><surname>Bal</surname> <given-names>AM</given-names></name><name><surname>Bassetti</surname> <given-names>M</given-names></name><name><surname>Bonnet</surname> <given-names>E</given-names></name><name><surname>Chan</surname> <given-names>M</given-names></name><name><surname>Coombs</surname> <given-names>G</given-names></name><name><surname>Dancer</surname> <given-names>SJ</given-names></name><name><surname>David</surname> <given-names>MZ</given-names></name><name><surname>De Simone</surname> <given-names>G</given-names></name><name><surname>Dryden</surname> <given-names>M</given-names></name><name><surname>Guardabassi</surname> <given-names>L</given-names></name><name><surname>Hanitsch</surname> <given-names>LG</given-names></name><name><surname>Hijazi</surname> <given-names>K</given-names></name><name><surname>Krüger</surname> <given-names>R</given-names></name><name><surname>Lee</surname> <given-names>A</given-names></name><name><surname>Leistner</surname> <given-names>R</given-names></name><name><surname>Pagliano</surname> <given-names>P</given-names></name><name><surname>Righi</surname> <given-names>E</given-names></name><name><surname>Schneider-Burrus</surname> <given-names>S</given-names></name><name><surname>Skov</surname> <given-names>RL</given-names></name><name><surname>Tattevin</surname> <given-names>P</given-names></name><name><surname>Van Wamel</surname> <given-names>W</given-names></name><name><surname>Vos</surname> <given-names>MC</given-names></name><name><surname>Voss</surname> <given-names>A</given-names></name><collab>International Society of Chemotherapy</collab></person-group><year iso-8601-date="2018">2018</year><article-title>Panton-Valentine leukocidin-positive <italic>Staphylococcus aureus</italic>: a position statement from the International Society of Chemotherapy</article-title><source>International Journal of Antimicrobial Agents</source><volume>51</volume><fpage>16</fpage><lpage>25</lpage><pub-id pub-id-type="doi">10.1016/j.ijantimicag.2017.11.002</pub-id><pub-id pub-id-type="pmid">29174420</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shallcross</surname> <given-names>LJ</given-names></name><name><surname>Fragaszy</surname> <given-names>E</given-names></name><name><surname>Johnson</surname> <given-names>AM</given-names></name><name><surname>Hayward</surname> <given-names>AC</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>The role of the Panton-Valentine leucocidin toxin in staphylococcal disease: a systematic review and meta-analysis</article-title><source>The Lancet Infectious Diseases</source><volume>13</volume><fpage>43</fpage><lpage>54</lpage><pub-id pub-id-type="doi">10.1016/S1473-3099(12)70238-4</pub-id><pub-id pub-id-type="pmid">23103172</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sheppard</surname> <given-names>SK</given-names></name><name><surname>Didelot</surname> <given-names>X</given-names></name><name><surname>Meric</surname> <given-names>G</given-names></name><name><surname>Torralbo</surname> <given-names>A</given-names></name><name><surname>Jolley</surname> <given-names>KA</given-names></name><name><surname>Kelly</surname> <given-names>DJ</given-names></name><name><surname>Bentley</surname> <given-names>SD</given-names></name><name><surname>Maiden</surname> <given-names>MC</given-names></name><name><surname>Parkhill</surname> <given-names>J</given-names></name><name><surname>Falush</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Genome-wide association study identifies vitamin B5 biosynthesis as a host specificity factor in campylobacter</article-title><source>PNAS</source><volume>110</volume><fpage>11923</fpage><lpage>11927</lpage><pub-id pub-id-type="doi">10.1073/pnas.1305559110</pub-id><pub-id pub-id-type="pmid">23818615</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sina</surname> <given-names>H</given-names></name><name><surname>Ahoyo</surname> <given-names>TA</given-names></name><name><surname>Moussaoui</surname> <given-names>W</given-names></name><name><surname>Keller</surname> <given-names>D</given-names></name><name><surname>Bankolé</surname> <given-names>HS</given-names></name><name><surname>Barogui</surname> <given-names>Y</given-names></name><name><surname>Stienstra</surname> <given-names>Y</given-names></name><name><surname>Kotchoni</surname> <given-names>SO</given-names></name><name><surname>Prévost</surname> <given-names>G</given-names></name><name><surname>Baba-Moussa</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Variability of antibiotic susceptibility and toxin production of <italic>staphylococcus aureus</italic> strains isolated from skin, soft tissue, and bone related infections</article-title><source>BMC Microbiology</source><volume>13</volume><elocation-id>188</elocation-id><pub-id pub-id-type="doi">10.1186/1471-2180-13-188</pub-id><pub-id pub-id-type="pmid">23924370</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spaan</surname> <given-names>AN</given-names></name><name><surname>Henry</surname> <given-names>T</given-names></name><name><surname>van Rooijen</surname> <given-names>WJM</given-names></name><name><surname>Perret</surname> <given-names>M</given-names></name><name><surname>Badiou</surname> <given-names>C</given-names></name><name><surname>Aerts</surname> <given-names>PC</given-names></name><name><surname>Kemmink</surname> <given-names>J</given-names></name><name><surname>de Haas</surname> <given-names>CJC</given-names></name><name><surname>van Kessel</surname> <given-names>KPM</given-names></name><name><surname>Vandenesch</surname> <given-names>F</given-names></name><name><surname>Lina</surname> <given-names>G</given-names></name><name><surname>van Strijp</surname> <given-names>JAG</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>The staphylococcal toxin Panton-Valentine leukocidin targets human C5a receptors</article-title><source>Cell Host &amp; Microbe</source><volume>13</volume><fpage>584</fpage><lpage>594</lpage><pub-id pub-id-type="doi">10.1016/j.chom.2013.04.006</pub-id><pub-id pub-id-type="pmid">23684309</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stamatakis</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>RAxML version 8: a tool for phylogenetic analysis and post-analysis of large phylogenies</article-title><source>Bioinformatics</source><volume>30</volume><fpage>1312</fpage><lpage>1313</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btu033</pub-id><pub-id pub-id-type="pmid">24451623</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stegger</surname> <given-names>M</given-names></name><name><surname>Wirth</surname> <given-names>T</given-names></name><name><surname>Andersen</surname> <given-names>PS</given-names></name><name><surname>Skov</surname> <given-names>RL</given-names></name><name><surname>De Grassi</surname> <given-names>A</given-names></name><name><surname>Simões</surname> <given-names>PM</given-names></name><name><surname>Tristan</surname> <given-names>A</given-names></name><name><surname>Petersen</surname> <given-names>A</given-names></name><name><surname>Aziz</surname> <given-names>M</given-names></name><name><surname>Kiil</surname> <given-names>K</given-names></name><name><surname>Cirković</surname> <given-names>I</given-names></name><name><surname>Udo</surname> <given-names>EE</given-names></name><name><surname>del Campo</surname> <given-names>R</given-names></name><name><surname>Vuopio-Varkila</surname> <given-names>J</given-names></name><name><surname>Ahmad</surname> <given-names>N</given-names></name><name><surname>Tokajian</surname> <given-names>S</given-names></name><name><surname>Peters</surname> <given-names>G</given-names></name><name><surname>Schaumburg</surname> <given-names>F</given-names></name><name><surname>Olsson-Liljequist</surname> <given-names>B</given-names></name><name><surname>Givskov</surname> <given-names>M</given-names></name><name><surname>Driebe</surname> <given-names>EE</given-names></name><name><surname>Vigh</surname> <given-names>HE</given-names></name><name><surname>Shittu</surname> <given-names>A</given-names></name><name><surname>Ramdani-Bougessa</surname> <given-names>N</given-names></name><name><surname>Rasigade</surname> <given-names>JP</given-names></name><name><surname>Price</surname> <given-names>LB</given-names></name><name><surname>Vandenesch</surname> <given-names>F</given-names></name><name><surname>Larsen</surname> <given-names>AR</given-names></name><name><surname>Laurent</surname> <given-names>F</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Origin and evolution of european community-acquired methicillin-resistant <italic>Staphylococcus aureus</italic></article-title><source>mBio</source><volume>5</volume><elocation-id>e01044</elocation-id><pub-id pub-id-type="doi">10.1128/mBio.01044-14</pub-id><pub-id pub-id-type="pmid">25161186</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tseng</surname> <given-names>CW</given-names></name><name><surname>Kyme</surname> <given-names>P</given-names></name><name><surname>Low</surname> <given-names>J</given-names></name><name><surname>Rocha</surname> <given-names>MA</given-names></name><name><surname>Alsabeh</surname> <given-names>R</given-names></name><name><surname>Miller</surname> <given-names>LG</given-names></name><name><surname>Otto</surname> <given-names>M</given-names></name><name><surname>Arditi</surname> <given-names>M</given-names></name><name><surname>Diep</surname> <given-names>BA</given-names></name><name><surname>Nizet</surname> <given-names>V</given-names></name><name><surname>Doherty</surname> <given-names>TM</given-names></name><name><surname>Beenhouwer</surname> <given-names>DO</given-names></name><name><surname>Liu</surname> <given-names>GY</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title><italic>Staphylococcus aureus</italic> Panton-Valentine leukocidin contributes to inflammation and muscle tissue injury</article-title><source>PLoS ONE</source><volume>4</volume><elocation-id>e6387</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0006387</pub-id><pub-id pub-id-type="pmid">19633710</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vandenesch</surname> <given-names>F</given-names></name><name><surname>Naimi</surname> <given-names>T</given-names></name><name><surname>Enright</surname> <given-names>MC</given-names></name><name><surname>Lina</surname> <given-names>G</given-names></name><name><surname>Nimmo</surname> <given-names>GR</given-names></name><name><surname>Heffernan</surname> <given-names>H</given-names></name><name><surname>Liassine</surname> <given-names>N</given-names></name><name><surname>Bes</surname> <given-names>M</given-names></name><name><surname>Greenland</surname> <given-names>T</given-names></name><name><surname>Reverdy</surname> <given-names>ME</given-names></name><name><surname>Etienne</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Community-acquired methicillin-resistant <italic>staphylococcus aureus</italic> carrying Panton-Valentine leukocidin genes: worldwide emergence</article-title><source>Emerging Infectious Diseases</source><volume>9</volume><fpage>978</fpage><lpage>984</lpage><pub-id pub-id-type="doi">10.3201/eid0908.030089</pub-id><pub-id pub-id-type="pmid">12967497</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Verma</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Pyomyositis in children</article-title><source>Current Infectious Disease Reports</source><volume>18</volume><elocation-id>12</elocation-id><pub-id pub-id-type="doi">10.1007/s11908-016-0520-2</pub-id><pub-id pub-id-type="pmid">26879741</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Villaruz</surname> <given-names>AE</given-names></name><name><surname>Bubeck Wardenburg</surname> <given-names>J</given-names></name><name><surname>Khan</surname> <given-names>BA</given-names></name><name><surname>Whitney</surname> <given-names>AR</given-names></name><name><surname>Sturdevant</surname> <given-names>DE</given-names></name><name><surname>Gardner</surname> <given-names>DJ</given-names></name><name><surname>DeLeo</surname> <given-names>FR</given-names></name><name><surname>Otto</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>A point mutation in the agr locus rather than expression of the Panton-Valentine leukocidin caused previously reported phenotypes in <italic>staphylococcus aureus</italic> pneumonia and gene regulation</article-title><source>The Journal of Infectious Diseases</source><volume>200</volume><fpage>724</fpage><lpage>734</lpage><pub-id pub-id-type="doi">10.1086/604728</pub-id><pub-id pub-id-type="pmid">19604047</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wick</surname> <given-names>RR</given-names></name><name><surname>Judd</surname> <given-names>LM</given-names></name><name><surname>Gorrie</surname> <given-names>CL</given-names></name><name><surname>Holt</surname> <given-names>KE</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Unicycler: resolving bacterial genome assemblies from short and long sequencing reads</article-title><source>PLOS Computational Biology</source><volume>13</volume><elocation-id>e1005595</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pcbi.1005595</pub-id><pub-id pub-id-type="pmid">28594827</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xia</surname> <given-names>G</given-names></name><name><surname>Wolz</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Phages of <italic>staphylococcus aureus</italic> and their impact on host evolution</article-title><source>Infection, Genetics and Evolution</source><volume>21</volume><fpage>593</fpage><lpage>601</lpage><pub-id pub-id-type="doi">10.1016/j.meegid.2013.04.022</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Young</surname> <given-names>BC</given-names></name><name><surname>Golubchik</surname> <given-names>T</given-names></name><name><surname>Batty</surname> <given-names>EM</given-names></name><name><surname>Fung</surname> <given-names>R</given-names></name><name><surname>Larner-Svensson</surname> <given-names>H</given-names></name><name><surname>Votintseva</surname> <given-names>AA</given-names></name><name><surname>Miller</surname> <given-names>RR</given-names></name><name><surname>Godwin</surname> <given-names>H</given-names></name><name><surname>Knox</surname> <given-names>K</given-names></name><name><surname>Everitt</surname> <given-names>RG</given-names></name><name><surname>Iqbal</surname> <given-names>Z</given-names></name><name><surname>Rimmer</surname> <given-names>AJ</given-names></name><name><surname>Cule</surname> <given-names>M</given-names></name><name><surname>Ip</surname> <given-names>CL</given-names></name><name><surname>Didelot</surname> <given-names>X</given-names></name><name><surname>Harding</surname> <given-names>RM</given-names></name><name><surname>Donnelly</surname> <given-names>P</given-names></name><name><surname>Peto</surname> <given-names>TE</given-names></name><name><surname>Crook</surname> <given-names>DW</given-names></name><name><surname>Bowden</surname> <given-names>R</given-names></name><name><surname>Wilson</surname> <given-names>DJ</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Evolutionary dynamics of <italic>staphylococcus</italic> aureus during progression from carriage to disease</article-title><source>PNAS</source><volume>109</volume><fpage>4550</fpage><lpage>4555</lpage><pub-id pub-id-type="doi">10.1073/pnas.1113219109</pub-id><pub-id pub-id-type="pmid">22393007</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zerbino</surname> <given-names>DR</given-names></name><name><surname>Birney</surname> <given-names>E</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Velvet: algorithms for de novo short read assembly using de bruijn graphs</article-title><source>Genome Research</source><volume>18</volume><fpage>821</fpage><lpage>829</lpage><pub-id pub-id-type="doi">10.1101/gr.074492.107</pub-id><pub-id pub-id-type="pmid">18349386</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname> <given-names>X</given-names></name><name><surname>Stephens</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Genome-wide efficient mixed-model analysis for association studies</article-title><source>Nature Genetics</source><volume>44</volume><fpage>821</fpage><lpage>824</lpage><pub-id pub-id-type="doi">10.1038/ng.2310</pub-id><pub-id pub-id-type="pmid">22706312</pub-id></element-citation></ref></ref-list></back><sub-article article-type="decision-letter" id="SA1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.42486.018</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group><contrib contrib-type="editor"><name><surname>Parkhill</surname><given-names>Julian</given-names></name><role>Reviewing Editor</role><aff><institution>The Wellcome Trust Sanger Institute</institution><country>United Kingdom</country></aff></contrib><contrib contrib-type="reviewer"><name><surname>Lees</surname><given-names>John</given-names> </name><role>Reviewer</role><aff><institution>NYUMC</institution><country>United States</country></aff></contrib></contrib-group></front-stub><body><boxed-text><p>In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.</p></boxed-text><p>Thank you for submitting your article &quot;Panton-Valentine leukocidin is the key determinant of <italic>Staphylococcus aureus</italic> pyomyositis in a bacterial GWAS&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by three peer reviewers, one of whom is a member of our Board of Reviewing Editors, and the evaluation has been overseen by Wendy Garrett as the Senior Editor. The following individual involved in the review of your submission has agreed to reveal his identity: John Lees (Reviewer #2).</p><p>The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.</p><p>Summary:</p><p>The authors use genome-wide association approaches to identify Panton-Valentine leucocidin as the primary determinant of disease causation in <italic>S. aureus</italic> pyomyositis.</p><p>Pyomyositis is purulent infection of skeletal muscles and associated with abscess formation. There is a strong association of the pathogen <italic>S. aureus</italic> with pyomyositis, 90% of cases in tropical regions, and ~75% in temperate regions. This study, by a team with strong track record in tropical medicine, and GWAS, links Panton-Valentine Leucocidin (PVL), a prophage-associated virulence determinant that is variably found in the <italic>S. aureus</italic> population, to pyomyositis. Their work provides strong evidence for the important role of the PVL toxin in pyomyositis in a paediatric cohort in Cambodia. Whilst there have been some controversies about the role that PVL plays in particular models of disease, there is strong clinical evidence for the association of PVL with some diseases, particularly skin and soft tissue infections (SSTIs), where the formation of boils and carbuncles are common. Abscess formation is a common link between pyomyositis and SSTIs.</p><p>The manuscript is a strong contribution to the field of association studies in bacteria. They have used a carefully collected, well-matched and well phenotyped sample collection, and properly applied cutting edge mathematical approaches. The design of the study, both in the sampling and use GWAS for analysis, is appropriate for answering the question the authors set out. Also valuable is the use of long-read sequencing to resolve the region of interest in all samples. The manuscript will settle some of the controversy about the role of PV toxin, at least in this disease context.</p><p>This paper has the potential to bridge the gap from candidate gene studies of PVL to more useful GWAS approaches, possibly leading to further meta-analysis in other populations.</p><p>Essential revisions:</p><p>1) In the Introduction and Discussion the authors state that they are trying to expand GWAS from the identification of variants under very strong selection, such as antibiotic resistance, into more subtle phenotypes with lower effects. However, there are two issues with this: i) bacterial GWAS has already been used to identify variants underlying subtle and non-resistance phenotypes. For just a few examples, see their reference 1, which analysed host preference in Campylobacter, their reference 4, which identified variants associated with invasiveness in S. pyogenes, PMID: 28742023, which looked at determinants of carriage duration in S. pneumoniae, PMID: 27997216, PMID: 28112723, PMID: 28785103, to name a few. The point about the strong selection on AMR vs. MGEs breaking up population structure is useful to make here, but instead of setting up an implication of this being the first non-proof-of-principle GWAS, please cite these studies instead. ii) The variant they have found has an enormous odds ratio, and is clearly under very strong selection. These sections should be toned down and the relevant literature cited.</p><p>2) It is unclear from the manuscript how valid the question the authors set out to answer actually is i.e. how controversial is the role of PVL in SSTIs? Reading the introduction and some of the cited references it does look like epidemiological studies have generally supported a role of PVL in SSTIs. Taken together with work in animal models, which seem to have been overlooked in this paper's introduction and references (an example of such a reference would be PMID 23684309), one might view this study as a confirmation of the role of PVL, rather than resolving an ongoing debate. The Introduction therefore needs more details and referencing to describe the controversy of the PVL association, whether this is really an ongoing debate, and why GWAS is needed to resolve this.</p><p>3) It was not clear how the high proportion of heritability explained by the PVL hit was estimated. This is a major result of this paper and should be clear. Furthermore, given the small number of samples, is it possible to provide a confidence interval, perhaps based on bootstrapping?</p><p>4) The use of non-USA/MRSA samples is an important strength of this study (as the authors note). Can the authors provide a more quantitative justification for this advantage? It is not necessary to perform a full meta-analysis or replication study in another population, but a summary of PVL vs SSTI presence/absence in another (more frequently studied e.g. MRSA) population would be useful to support this argument.</p><p>5) Given the multifaceted mechanisms of <italic>S. aureus</italic> that modulate host-cell interactions, it is not unreasonable to suppose that there are multiple factors that contribute to pathogenic processes involved in pyomyositis. From a pathological point of view, prior to the formation of abscesses that characterize pyomyositis, there is haematogenous spread of the pathogen, and therefore survival in the blood will be an important step in the disease process. In the authors' analysis PVL clearly demonstrates a strong association. However, the paper does not extend this to examine if there are other signals beyond PVL. Figure 2A shows that there are other associations outside the prophage reaching significance and which may provide clues to other determinants contributing to disease. These should be reported and discussed.</p><p>6) The authors have generated a strong hypothesis for the role of PVL in disease, but this is where the study ends. There is no mechanistic support for this through experimentation, or any discussion, which relates it to the pathology of disease or the cellular mechanisms involved. We agree that it is beyond the scope of the study to perform experimental work to probe the mechanistic link, but it would be helpful if the discussion were to explore the mechanistic basis of their observations and link it to pathogenicity.</p><p>7) The authors do not explore the relationship of the PVL carrying prophages within the <italic>S. aureus</italic> population in the study. This is an important aspect of the genetics of <italic>S. aureus</italic> of this data set that impinges on disease potential. What is the diversity of the prophages observed, where are they integrated, is there evidence of PVL mobility within and between lineages? This is an element of analysis that would add to the story, and link this back to the pathogen and our understanding of its ability to cause disease.</p></body></sub-article><sub-article article-type="reply" id="SA2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.42486.019</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Essential revisions:</p><p>1) In the Introduction and Discussion the authors state that they are trying to expand GWAS from the identification of variants under very strong selection, such as antibiotic resistance, into more subtle phenotypes with lower effects. However, there are two issues with this: i) bacterial GWAS has already been used to identify variants underlying subtle and non-resistance phenotypes. For just a few examples, see their reference 1, which analysed host preference in Campylobacter, their reference 4, which identified variants associated with invasiveness in S. pyogenes, PMID: 28742023, which looked at determinants of carriage duration in S. pneumoniae, PMID: 27997216, PMID: 28112723, PMID: 28785103, to name a few. The point about the strong selection on AMR vs. MGEs breaking up population structure is useful to make here, but instead of setting up an implication of this being the first non-proof-of-principle GWAS, please cite these studies instead. ii) The variant they have found has an enormous odds ratio, and is clearly under very strong selection. These sections should be toned down and the relevant literature cited.</p></disp-quote><p>We would like to thank the reviewers for these important points. We have modified our Introduction to include recent results, and note the phenotypes where GWAS has demonstrated an association (host specificity, invasive disease with <italic>Streptococcus pyogenes</italic> and <italic>Staphylococcus epidermidis</italic>, pneumococcal carriage, mortality following bacteraemia with CC-30 <italic>Staphylococcus aureus</italic>, endemic melioidosis). We have noted in discussion that the strong effect size contributes the success of this study. We have moderated the language in discussion about the importance of MGEs by noting that a large effect size was present in this study.</p><disp-quote content-type="editor-comment"><p>2) It is unclear from the manuscript how valid the question the authors set out to answer actually is i.e. how controversial is the role of PVL in SSTIs? Reading the introduction and some of the cited references it does look like epidemiological studies have generally supported a role of PVL in SSTIs. Taken together with work in animal models, which seem to have been overlooked in this paper's introduction and references (an example of such a reference would be PMID 23684309), one might view this study as a confirmation of the role of PVL, rather than resolving an ongoing debate. The Introduction therefore needs more details and referencing to describe the controversy of the PVL association, whether this is really an ongoing debate, and why GWAS is needed to resolve this.</p></disp-quote><p>It is important to clarify that our study is of pyomyositis, not skin and soft tissue infections. As the reviewers observe, PVL is widely accepted as a virulence factor for superficial skin and soft tissue infections such as abscesses, boils and furunculosis (see Shallcross et al., 2013 and Saeed et al., 2017). However pyomyositis remains a distinct entity of invasive disease observed in tropical areas, with the formation of purulent infection within skeletal muscle, while the overlying skin remains intact. Unlike infections of the skin and superficial soft tissues, the skin and subcutaneous tissues are not usually involved in pyomyositis, by contrast to intense inflammation in the infected muscles. Pyomyositis is thought to arise from haematogenous seeding of bacteria from blood to muscle (See Verma et al., 2016). Reviews of the role of PVL in disease – including the two cited here – generally separate it from skin and soft tissue infections, categorising it among musculoskeletal infections.</p><p>We have researched the question extensively and believe that the studies supporting and refuting the association of PVL are yet to provide an unequivocal answer to the question. In conducting this study, we started without a hypothesis that we would find specific causative genes associated with pyomyositis; our aim was to investigate whether any bacterial genetic factors contribute to the characteristic disease entity of pyomyositis. Given the striking results localised to a single gene, and because prominent results reporting association between PVL with other conditions (e.g. necrotising pneumonia) have been controversial, we chose to contextualise the results early with a discussion of PVL as a virulence factor, including what is known about its possible contribution to pyomyositis. However, the discussion of PVL in the introduction should not indicate that this was a study designed to investigate the role of PVL in pyomyositis. We have clarified this further in the Introduction.</p><p>We would strongly contend that no strong evidence establishes an association between PVL and pyomyositis prior to this study. Indeed, in the article on mechanisms of action of PVL suggested here (PMID 23684309), the authors note “the role of PVL is still under debate”. In the meta-analysis conducted by Shallcross et al., the authors find that in contrast to the strong association with skin and soft tissue infections, PVL strains are comparatively rare in musculoskeletal infections (OR 0.44, CI 0.19-0.99). In the ISAC position statement on PVL, they find the association between PVL and SSTI is highest for furuncuolisis. This review presents limited statements on musculoskeletal infection. They do note “PVL-SA are also associated with severe musculoskeletal infections, particularly in children”, but the only evidence they present (Sheikh et al., 2015, British Journal of hospital medicine) is a review specifically of osteomyelitis. It is notable that this review cites as evidence the meta-analysis by Shallcross et al., which found existing evidence for an association between musculoskeletal infection and PVL was weak. The review by Sheikh et al. further supports the claims of association with studies that report non-significant results on tests of association: “Panton-Valentine leukocidin-producing <italic>S. aureus</italic> osteomyelitis can be multifocal with multiple bones involved. Patients are also more likely to present with large sub-periosteal abscesses (risk ratio 3.90, <italic>P</italic>=0.25) […] and associated myositis and/or pyomyositis (risk ratio 3.22, <italic>P</italic>=0.18)[…].”</p><p>To address this concern, and to avoid any unintended confusion between pyomyositis and superficial SSTI, we have therefore included further detail throughout our introduction to reiterate the aims of this study (to undertake an unbiased survey of the whole genome, rather than hypothesis driven investigation), and its focus on the invasive, distinctive pathological entity of pyomyositis rather than superficial skin and soft tissue infection. We have also expanded the literature review to clearly state why we believe our results illuminate an ongoing debate rather than confirm a settled answer.</p><disp-quote content-type="editor-comment"><p>3) It was not clear how the high proportion of heritability explained by the PVL hit was estimated. This is a major result of this paper and should be clear. Furthermore, given the small number of samples, is it possible to provide a confidence interval, perhaps based on bootstrapping?</p></disp-quote><p>We determined this figure by including the presence of the most significant kmer, which tags PVL, as a covariate in the linear mixed model. When this is included, the estimate of heritability output by the model (in GEMMA), which represents the estimated proportion of heritability not explained by other factors, drops from 63.8% to 0.0%. Thus, the proportion of difference explained ((p1-p2)/p1) is over 99.99% (95% CI 93.5-100%). We have included this more detailed description of the heritability results (Results paragraph seven), including the confidence interval for proportion accounted for, and added to the relevant Materials and methods section (subsection “Genome wide association testing of Kmers.”).</p><disp-quote content-type="editor-comment"><p>4) The use of non-USA/MRSA samples is an important strength of this study (as the authors note). Can the authors provide a more quantitative justification for this advantage? It is not necessary to perform a full meta-analysis or replication study in another population, but a summary of PVL vs SSTI presence/absence in another (more frequently studied e.g. MRSA) population would be useful to support this argument.</p></disp-quote><p>With apologies, we do not understand what this question seeks to address. We do not believe that evidence about prevalence of PVL in skin and soft tissue infections can be directly applied to help our understanding of primary, invasive muscle infection. Regarding pyomyositis, limited studies exist. Our paper references a meta-analysis, which summarises the prevalence of PVL in existing high-quality studies of musculoskeletal infections. Only two of these studies were of pyomyositis (the rest being bone and joint infections), and neither had carriage control populations (one had skin and soft tissue infections as a comparator group, and the other was a case series without control group). The findings and limitations of studies of CA-MRSA and pyomyositis are detailed in the Discussion.</p><disp-quote content-type="editor-comment"><p>5) Given the multifaceted mechanisms of S. aureus that modulate host-cell interactions, it is not unreasonable to suppose that there are multiple factors that contribute to pathogenic processes involved in pyomyositis. From a pathological point of view, prior to the formation of abscesses that characterize pyomyositis, there is haematogenous spread of the pathogen, and therefore survival in the blood will be an important step in the disease process. In the authors' analysis PVL clearly demonstrates a strong association. However, the paper does not extend this to examine if there are other signals beyond PVL. Figure 2A shows that there are other associations outside the prophage reaching significance and which may provide clues to other determinants contributing to disease. These should be reported and discussed.</p></disp-quote><p>This is an important point, and the incomplete penetrance of PVL suggests other factors (host, bacterial or environmental) in the pathogenic process. However, we have little evidence for any remaining bacterial genetic heritability (see point 3 above for a formal demonstration of this). Following the reviewers’ suggestion, we have included a discussion of the analysis of significant kmers outside of the prophage region (Results paragraph six, Supplementary file 2). These findings are cautiously interpreted, given the very low remaining heritability once PVL is accounted for.</p><disp-quote content-type="editor-comment"><p>6) The authors have generated a strong hypothesis for the role of PVL in disease, but this is where the study ends. There is no mechanistic support for this through experimentation, or any discussion, which relates it to the pathology of disease or the cellular mechanisms involved. We agree that it is beyond the scope of the study to perform experimental work to probe the mechanistic link, but it would be helpful if the discussion were to explore the mechanistic basis of their observations and link it to pathogenicity.</p></disp-quote><p>We agree, this is a helpful addition to the observations of our study. We have included discussion on the extensive experimental work that has previously reported plausible mechanism for the action of PVL in muscle infections (Discussion section).</p><disp-quote content-type="editor-comment"><p>7) The authors do not explore the relationship of the PVL carrying prophages within the S. aureus population in the study. This is an important aspect of the genetics of S. aureus of this data set that impinges on disease potential. What is the diversity of the prophages observed, where are they integrated, is there evidence of PVL mobility within and between lineages? This is an element of analysis that would add to the story, and link this back to the pathogen and our understanding of its ability to cause disease.</p></disp-quote><p>We agree this is a helpful development of the study results. We have added a section in results discussing the diversity of phages within and between lineages (Discussion paragraph nine, (see also Figure 2—figure supplement 4, Supplementary file 3). There are challenges to the study of phages with short read sequencing data; in almost all isolates the likely phage sequences are fragmented, so an analysis of the integration of prophages is not currently possible. However we think the question of phage integration throughout the population, while an important question, is incidental to the current study’s main result.</p></body></sub-article></article>